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ABSTRACT 
CECILIA FABRIZIO: Physicians‟ Perceptions of the Hong Kong Cervical Screening 
Programme: Implications for Improving Cervical Health 
 (Under the direction of Christopher Shea, PhD) 
 
Background: The incidence and mortality rates of cervical cancer are disproportionately 
higher in Hong Kong than in developed countries with similar resources.  In 2004 the Hong 
Kong government introduced the Cervical Screening Program (CSP) to increase the 
population screening coverage rates, and to reduce the incidence and mortality of cervical 
cancer.  Seven years after the launch of the program, proximal outcomes are disappointing; 
registration among both physicians and women is below twenty percent of those eligible, and 
there have been negligible changes in rates of screening.  
Objective: The purpose of this study was to inform policy considerations by exploring the 
under-participation of practitioners in the CSP.  
Methods: Using both snowball and purposeful sampling, sixteen physician key informants 
were interviewed to explore the factors that might influence their decisions to participate in 
the program.  Rogers‟ Diffusion of Innovations, and its focus on the individual‟s adoption-
decision process, served as a theoretical framework for analysis. Data were coded, and then 
analyzed in matrix displays for themes and higher-level analysis.  This analysis was 
conducted by key variables such as specialty, gender, or CSP registration status.  As themes 
emerged, they were summarized into findings, illustrated by quotes. 
  
iv 
Results: Several themes emerged to suggest the benefits and barriers that might influence 
CSP participation, including a lack of benefits that were meaningful to the physicians; 
administrative cost and complexity; and polices that were incompatible with physicians‟ 
usual care practices.  
Recommendations: The data from this study indicate that the CSP‟s characteristics are 
limiting physicians‟ participation in the program.  Importantly, the CSP does not influence 
rates of overscreening among those physicians who currently conduct cervical screening, nor 
does the CSP overcome the obstacles to screening among physicians who do not do much 
screening. A Plan for Change is presented that uses the study findings and the lack of 
program outcomes to inform and influence cervical screening policy makers.  Strategic 
recommendations suggest refocusing cervical screening policies and strengthening efforts to 
increase the uptake among underscreened women.  The plan recommends the use of specific 
advocacy leadership skills to build support and influence, while working toward an 
opportune policy window for change. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
I. Statement of the Issue 
 
Cervical cancer is the second most common female cancer worldwide after 
breast cancer, with estimates of over 500,000 new cases and more than 288,000 
deaths per year (International Agency for Research on Cancer, 2005).  Cervical 
cancer is unique among cancers in that its cause is known, it can be identified early 
and it can be treated effectively at a pre-cancerous stage.  The most common 
screening test, the Papanicolaou smear (Pap test) is relatively inexpensive, widely 
available, and reasonably acceptable to women.  As a result of the Pap test, 
government-organized screening programs in many developed countries, and 
opportunistic screening in many other countries, the global burden of cervical cancer 
has fallen in the last forty years.   
Hong Kong women suffer from a disproportionately higher incidence of 
preventable morbidity and mortality from cervical cancer than women in similarly 
industrialized countries, as shown in Figures 1  &  2.  These relatively higher rates are 
attributed to low rates of screening among women overall, and in particular, low 
screening rates among older and low-income women.   
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Figure 1: Age-standardized Cervical Cancer   Figure 2: Age-standardized Cervical Cancer 
   Incidence Rates       Mortality Rates 
 
(Hong Kong Department of Health, 2009)  
In 2004 the Hong Kong government introduced the Cervical Screening 
Program (CSP) with the objectives of increasing the population screening coverage 
rates and reducing the incidence and mortality of cervical cancer.  Parallel strategies 
targeted: a) physicians to motivate them to increase the uptake of their patients; and 
b) women to take up regular screening.  Both physicians and women were invited to 
register with the CSP and thus voluntarily build up a registry of data. Other countries 
do not have this type of voluntary system so it is difficult to compare results, however 
publicly available data show that proximal outcomes are disappointing.  Registration 
among both physicians and women is below twenty percent of those eligible and 
there have been negligible changes in rates of screening. 
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II. Study Aims  
Given Hong Kong women‟s disproportionate rates of cervical cancer and low 
participation in the CSP, this research aimed to understand the CSP‟s role in 
impacting cervical screening rates.  Cervical screening rates can be influenced either 
directly, by attempting to change the behavior of the women, or indirectly, by 
working with physicians to recommend screening to their patients.  The determinants 
of cervical cancer screening have been studied in Hong Kong, however not much is 
known about factors that impact physician‟s recommendations for cervical screening.  
Therefore, this study focused on the efforts of the CSP to motivate physicians to 
increase screening among their patients.   
The purpose of this study was to explore the under-participation of private 
practitioners in the Hong Kong Cervical Cancer Screening Program by studying 
which factors influenced their adoption of the program.  The results of the study will 
inform policy considerations for potential policy improvements to the national CSP. 
 
III. Cervical Cancer Background 
Screening methods and diagnosis 
Cervical cancer‟s long, pre-invasive phase, which may extend as long as 10-
15 years, makes it an ideal target for a screening program. Mild dysplasia, or the 
presence of abnormal cells, is commonly detected with cytology; a process that 
collects exfoliated cells from the cervix, stains them,and examines them under a 
microscope.  Known as the “Pap test,” it was first developed by Papanicolaou and 
Babes in the 1920‟s although it was not widely used in Western countries until the 
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60‟s and 70‟s (Papanicolaou, 1928; Papanicolaou  &  Traut, 1941, as reported in 
International Agency for Research on Cancer, 2005).  
When Pap cytology is used as part of a broad-based screening program for 
cervical cancer, results are compelling.  Early descriptive studies comparing the 
incidence of cervical cancer in Finland and Sweden before and after the introduction 
of opportunistic screening, reported declines in incidence of 50% and 34%, 
respectively (Laara, Day, & Hakama, 1987).  Subsequent successful studies were 
designed as case-control or cohort follow-up studies (Clarke & Anderson, 1979; 
Hakama, Chamberlain, Day, Miller & Prorok, 1985).  Today, although results have 
never been established through rigorous scientific trials, scientific agreement on the 
Pap test‟s effectiveness from these quasi-experimental studies has made it virtually 
impossible to conduct a randomized controlled trial, as it would be considered 
unethical to withhold screening from women in the control group (International 
Agency for Research on Cancer, 2005). 
 
IV. Hong Kong Background 
Hong Kong burden of cervical cancer 
Cervical cancer was the ninth most common cause of female deaths in 2008, 
although the rate varies year to year and ranked as high as fifth in 2006.  In 2008 
there were 358 new cases, accounting for 3.1% of all new cancer cases in females.  
The median age at diagnosis was 53 years, with an age-standardized incidence rate of 
6.9%.  There were 120 deaths in 2008, with an age-standardized mortality rate of 
2.1% (Hospital Authority, 2011). 
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Incidence of cervical cancer has fallen during the recent 30-year period.  The 
Hong Kong Cancer Registry reports an overall age-adjusted cervical cancer rate of 
24.9 per 100,000 in the 1972-74 period, reduced to 9.5 per 100,000 in the 1999-2001 
period, for an average annual incidence reduction of 4.0%.  Figure 3 shows incidence 
and mortality rates from 1989-2009.  This reduction was most pronounced for women 
aged 30-65, although all ages showed some declines (Leung, et al., 2006).  This 
reduction parallels the introduction of the Pap test, followed by increasing rates of 
opportunistic screening over time, and the systematic introduction of routine cytology 
as part of government-provided antenatal care in the 1980‟s.  However this reduction 
in age-standardized incidence rates of about 50% from the 1980s is below that of 
developed countries where screening programs have been well organized.  For 
example, Finland‟s age-standardized incidence and mortality fell by 80% from 1963-
1990, and British Columbia, Canada‟s fell 70-80% from 1955-1985 (Day, Williams, 
Khaw, 1989).  More recently, Britain‟s organized screening program, launched in the 
late 1980‟s, generated reductions in incidence of 40% and mortality of almost 50% 
between 1988 and 1995 (Cancer Research UK, 2003). 
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Figure 3: Hong Kong Incidence and mortality rates of cervical cancer, 1989-2009 
 
(Hong Kong Hospital Authority, 2010) 
 
 
Similar to global data, the burden of cervical cancer in Hong Kong generally 
grows with increasing age, due to the long pre-invasive stage, post HPV infection 
(Figure 4).  Incidence and mortality are quite low before 25 years of age, and then rise 
sharply.  There is a peak in incidence for women in their 40s and 50s; however the 
highest incidence peak is among women aged 70–75 years.   
While Hong Kong‟s incidence profile for women through their 50‟s is 
consistent with most American, Asian and African registries, Hong Kong‟s incidence 
differs from global data for women in their 70‟s.  Those countries show continued 
declines in rates of invasive cancer while Hong Kong experiences a second peak 
(Gustafson et al., 1997).  Mortality rates rise from the age group 35-39 years to their 
highest levels for women in the age group 80-84 years. 
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Figure 4: Average age-specific incidence (2004-2008) and mortality (2005-2009) rates of malignant 
neoplasm of cervix uteri in Hong Kong,  
 
 
(Hong Kong Hospital Authority, 2010) 
 
An analysis of HPV infection prevalence compared to age-specific cervical 
cancer incidence helps explain this troubling trend.  Similar to global data, age-
specific HPV prevalence in Hong Kong shows two peaks, at 26-30 years and at 46-50 
years, similar to bimodal trends in many countries (Figure 5).  The first peak is 
followed by cervical intraepithelial neoplasia lesions (CIN2/3) and invasive cervical 
cancers (ICC) at 5-15 years and 15 years later, respectively.  However, while the 
second HPV peak is followed by ICC, it is not followed by a reported increase in 
CIN2/3 (Figures 6 & 7).  This likely indicates that this older cohort of women may 
not have been screened (Chan, et al., 2010). 
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Figure 5: Hong Kong age-specific incidence of HPV infection 
 
(Chan, et al., 2010) 
 
Figure 6: Hong Kong age-specific incidence of cervical intraepithelial neoplasia 
 
 
 
(Chan, et al., 2010) 
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Figure 7: Hong Kong age-specific incidence of invasive cervical cancer 
 
(Chan, et al., 2010) 
 
Hong Kong Primary Care Services Background 
Hong Kong has a public-private health care system.  Per a 2007 report by the 
Bauhinia Foundation, the majority of outpatient primary care visits (about 85%) were 
attributed to private medical or alternative medical practitioners, of which there are 
about 12,000.  The government provides the remaining 15% of outpatient 
consultations and the majority of secondary or tertiary care.  Despite an average of 
almost eight primary care visits a year, many women do not have a regular doctor, 
which limits continuity and comprehensiveness of care (Li, 2003).  In fact “doctor-
shopping,” that is the changing of doctors without professional referral even in a 
single illness episode, is common (Leung, CastanCameo, McGhee, Wong, & 
Johnston, 2003).   
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Cervical screening in Hong Kong 
Prior to the introduction of the CSP in 2004, cervical screening was done 
opportunistically or as part of general or well-women health checks offered by 
primary care providers.  Galbraith (2005) estimated that about 60% of screening was 
conducted through non-governmental organizations, such as the Family Planning 
Association, and governmental agencies, including the Department of Health‟s 
Maternal and Child Health Centres, Women Health Centres, and Elderly Health 
Clinics, as well as the government hospital system.  The remaining 40% was 
conducted in the private sector, which included single or group-based practitioners, 
and Well Women Clinics of private hospitals.  In the private sector relatively few 
physicians may be responsible for the majority of private screening as it was 
estimated that only 40% of male generalists offered cervical screening to their 
patients, although data were limited and somewhat dated (Dickinson & Chan, 2001).  
All but the most low-income women pay for their screens, even in the public sector, 
although the lower screening fees in the government clinics are an indirect subsidy 
(HK$100 in government clinics versus HK$200-$500 in the private sector, or about 
US$13 versus US$25-$65). 
In 1998, Adab, et al., (2004) estimated that the effectiveness of the territory‟s 
opportunistic screens in 1998 was equivalent to an organized program with about 
50% coverage and 10-year screening intervals.  However this screening was 
inefficient and inequitable, with poor coverage of those at risk and over-screening of 
a minority of women (Adab, McGhee, Yanova, Wong & Hedley, 2004).  Vaidya, et 
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al. (1999), described Hong Kong‟s system as one that is “inequitable, wastes 
resources, and results in avoidable cases of cervical cancer.” 
The Hong Kong government tracks cervical screening with an annual 
telephone-based study, the Behavioral Risk Factor Survey (BRFS).  This study is 
weighted by gender and age to make it more representative of the population.  The 
BRFS reported a rate of 63.9% ever-screened women in the summer of 2004, the year 
the Cervical Screening Program began (Hong Kong Department of Health, 2010).   
 
The Cervical Screening Program 
The Cervical Screening Program (CSP) was introduced with the objective of:  
 Increasing the population coverage rates of cervical screening among 
women 
 Reducing the incidence of cervical cancer 
 Reducing the mortality of cervical cancer 
The program was positioned as benefiting overall screening coverage, equitable 
and efficient screening, better support and collaboration between the public and 
private sector, and better quality management in the screening service itself, from 
smear-taking to cytological examination, and with referrals and management of 
follow-up (Hong Kong Department of Health Topical Health #4: Prevention and 
Screening of Cervical Cancer, 2003). 
 
CSP Policy Components 
The screening policy addressed the target group and screening intervals.  The 
target population was women between 25 to 65 years, with an interim target coverage 
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rate of 60% within three years after the program‟s launch, growing to 80-85% 
coverage over a longer period.  Based on Hong Kong epidemiology, local practice 
guidelines, and experience from overseas, the CSP recommended two initial 
consecutive screens, and if there were no abnormal results, follow-up screens every 
three years.  The CSP worked with the local medical societies in developing these 
guidelines and encouraged the societies to issue them to their medical constituencies.  
 
Cervical Screening Information System (CSIS) 
The CSIS was established by the Department of Health (DOH) for the 
following purposes: 
 As a central recall registry 
 To maintain information on screening history and results 
 To track utilization of screening service and follow-up results 
 To facilitate record linkage across service providers 
 To link cervical smear data to biopsy results for correlation of cytology and 
biopsy 
 To support quality assurance, evaluation, monitoring and research 
Both physicians and women were invited to register, individually.  Providers 
were asked to register themselves with the CSIS, and then to encourage their patients 
to register for the CSP and to be screened.  As an incentive, physicians who registered 
were offered information kits on smear taking, educational materials for their clients 
and training courses (Surveillance and Epidemiology Branch, Centre for Health 
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Protection, 2004).  The program also offered a recall system for their patients, and 
access to their screening history through a secure online system. 
Women were invited to register with the program, either through their doctor, 
online, or by mailing in a form.  They were required to consent to transfer their 
personal data and test results to the CSIS.  Registered providers could also submit the 
registered women‟s details into the database.  Women were required to use a 
password to access their screening history.  The database then issued an automatic 
recall for the patient at the appropriate interval.  The CSIS also promised to archive 
test results, email providers with details of patients recalled, and alert them of 
abnormal smears.   
 
CSP Quality Management  
 
The CSP sets criteria and guidelines for quality assurance and program delivery 
so that the program performance could be monitored for reliability and consistency.  
The CSP made specific technical recommendations for smear-taking, reporting and 
management of abnormal smears, and stipulated that all registered medical providers 
were allowed to take smears, including adequately trained and supervised nurses.  
CSP recommendations also included efforts to overcome barriers to screening, such 
as by encouraging professional education on communication with women.  The 
quality assurance standards included reduced time to inform women of test results 
and a guideline for women to be informed of all test results, positive or negative.   
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CSP Recruitment and education 
The program sought to collaborate with physicians and other service providers 
to encourage screening by providing data on screening, sending their patients 
reminder letters, setting up an enquiry system for cervical smear and biopsy results, 
and developing an informational website.  For women, a recruitment and education 
strategy was formulated to recruit the target population into the program.  
Communication aimed to ensure that women understand the reasons for cervical 
screening, the test and procedures involved, the results, and the treatment options. 
Mass media levels were significant at the program‟s launch, followed by low, 
maintenance levels of promotion.   
The CSP was not able to utilize national population listings for a “record and 
recall” system, due to local privacy constraints.  Therefore,the program has no 
capability of targeting high-risk women if they do not register.  Once a woman 
registers with the program and submits her Pap test results, the CSIS acts as a 
prospective recall system and sends her a reminder at the appropriate interval. 
The program was conceived as a public-private partnership, meaning that the 
government would determine the program guidelines but the private sector would 
provide the service.  The government consulted with stakeholders in the private sector 
in developing the framework of the program, and did not impose many regulations in 
its execution.   
Importantly the market sets prices for services, and no subsidy is provided to 
women to access care, nor to providers to increase participation.  Women can be 
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tested at their choice of a public or private health care provider, on a fee-for-service 
basis. Screening frequency is not monitored.   
Building on an understanding of Hong Kong‟s disproportionate burden of 
cancer, and the description of the Hong Kong Cervical Screening Program, the next 
section introduces the literature on cervical cancer screening programs, determinants 
of screening, and interventions to increase rates of screening, for application to the 
development of this study. 
 
  
 
 
 
 
 
 
CHAPTER 2 
 
REVIEW OF THE LITERATURE 
 
 
Hong Kong‟s CSP was intended to be a comprehensive program to increase the 
rates of cervical screening and decrease the incidence and mortality from cervical cancer. 
Therefore, a literature review was conducted to summarize the evidence for, and critical 
components of, cervical screening programs. This included both the evidence for 
screening programs in general and for cervical cancer screening programs in particular.  
In addition, the literature was searched for evidence on the determinants of screening and 
for interventions targeted to either women or physicians that increase women‟s 
participation in cervical screening. 
 
I. Search Methodology 
 
The computerized platform EBSCO was used to search the following 
individual online search engines, using their available cutoff publication dates as 
noted: Academic Search Premier (1975), PsychInfo (1975), Communication and 
Mass Media Complete (1915) and Health Source (1990).  PubMed was searched 
separately. 
The development of key terms was iterative.  The first approach was quite 
broad, using the words “cervical,” “cancer” and “screening” and/or “policy.”  These 
17 
 
results were then narrowed down by searching for a combination of these words, as 
noted below: 
Policy:  
For “policy,” “program,” and “regulation” were also used, but “policy” was the most 
fruitful search term. 
 
Program Evaluation: 
For “program evaluation,” “implementation,” “analysis,” and “evidence-based” were 
also used. 
 
Organized screening programs:  
“Organized screening programs” and “cancer screening” were searched separately, as 
well as “cervical cancer” and “Hong Kong.” 
 
Determinants of screening 
Psychosocial information was searched with the terms “psychosocial,” 
“determinants,” “barriers,” and “acceptability.” 
 
 
 
 
The references identified by the searches underwent an initial stage of 
assessment for relevance.  Then reference sections of studies from the search were 
examined for relevant articles.  These articles were identified and examined.  In 
addition, both the World Health Organization‟s International Agency for Research on 
Cancer‟s (IARC) handbook on Cervical Cancer Screening (2005), and the Hong 
Organized 
screening 
programs 
or  
Cancer 
Screening 
or  
Cervical 
Cancer 
or 
Hong Kong 
and 
 /  
or 
Policy 
or 
 Program 
or 
Regulation 
and 
/  
or 
 
Program 
Evaluation  
or 
Implementation 
or 
Analysis 
or 
Evidence-based 
and /  
or 
 
Determinants  
or 
Psychosocial 
or  
Barriers 
or 
Acceptability 
18 
 
Kong DOH report on cervical screening (2003) offered comprehensive literature 
reviews for further research.  Only studies published in English were included. 
Articles excluded were studies or papers that only focused on primary 
prevention, such as the HPV vaccine, and those not relevant to cancer screening 
policy and practices in Hong Kong, such as alternate screening methods in low 
resource countries. 
 
II. Search Results 
The evidence on cervical cancer screening is grouped into three main 
discussion areas: 1) evidence for the effectiveness, efficiency and equity of organized 
screening programs; 2) determinants of cervical cancer screening and; 3) 
interventions for women or physicians to increase participation in cervical screening.  
Where there is Hong Kong-specific evidence it is discussed in the appropriate section. 
 
Evidence for the effectiveness, efficiency and equity of organized screening 
programs  
Components of an organized screening program 
In 1993 the International Union against Cancer (UICC) summarized the 
components that successful programs shared in common, emphasizing the systematic 
roles of policy, active recruitment, quality assurance, evaluation, and monitoring:  
 The larger target population is identifiable 
 Individuals within the target population are identifiable 
19 
 
 Evidence-based recruitment methods are utilized to “guarantee” high coverage 
and attendance 
 Programs have adequate facilities for collecting and analysis of the screened 
materials 
 Programs have an organized quality control program for both screening and 
analysis of the screened materials 
 After screening there are adequate facilities and capacity to diagnose and treat the 
person with the confirmed disease 
 A referral system links the person screened, the laboratory, and the clinical 
provider for diagnosis and management of abnormal test results and for 
information about normal test results 
 At the population level, evaluation and monitoring distinguishes between those 
screened and those not screened (Hakama, 1993) 
 
Comparison of organized programs versus opportunistic programs 
Organized programs have been evaluated versus opportunistic programs on the 
basis of their impact on cancer incidence and mortality, their potential to reduce 
disparities, their cost effectiveness, and their effect on risk reduction for a population 
versus an individual.  Miles, et al. (2004), detailed how organized cancer screening 
programs had more potential to reduce the incidence and mortality of cancer than 
opportunistic programs.  This was due to their ability to achieve higher levels of 
population coverage for diagnosis (including facilitation of identification of 
underserved groups), their use of a centralized registry, and their inclusion of 
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mechanisms for follow-up and quality assurance.  When an organized program 
followed up on abnormal results, such as highlighted in the UICC description, it had 
the potential to increase the rates of diagnosis and treatment, and thereby reduce the 
rates of incidence and mortality (Miles, et al., 2004).  Conversely, opportunistic 
screening could be characterized by over-screening of some women, often performed 
by more expensive providers such as gynecologists, with low coverage of women of 
older age and/or low socioeconomic background.  In addition, test and reporting 
quality might not be consistent since it was not monitored systematically (Arbyn, et 
al, 2009). 
Although there was no evidence that either an organized or opportunistic 
screening model entirely eliminated disparities, organized programs helped promote 
equality of access (Miles, et al., 2004).  Importantly, access did not necessarily 
translate to equitable coverage, as this coverage was a function of the quality of the 
lists used to invite participants, the performance of the system issuing the invitation, 
and the relative participation levels of the target population.  Opportunistic screening 
might miss those at highest risk because it does not reach out to all women in the 
target population and address barriers to access.  Any particular woman‟s likelihood 
of being screened was influenced mainly by individual-level factors such as her 
physician, or her own knowledge, behavior, and access to care (Miles et al., 2004). 
Organized programs achieved a stronger level of cost-effectiveness than 
opportunistic programs by focusing on coverage of the target group at appropriate 
intervals.  Attendance rates were the major determinant of a program‟s health impact 
as well as its cost-effectiveness.  Therefore, for a given number of screens conducted, 
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the maximum impact in life-years gained came from reducing the over-screening of 
low-risk women and increasing the under-screening of high-risk women 
(Koopmanschap, 1990).  For example, in 1995 Norway established a national 
centralized system with obligatory registration of all cervical screening tests.  Three-
year coverage in the target group rose 7%, with increased participation of older and 
high-risk women; the number of smears fell 7%; and incidence declined 22% 
(Koopmanschap, van Oortmarssen, van Agt, van Ballegooijen, Habbema & Lubbe, 
2006).  
While opportunistic screening had few restrictions on quality, type and breadth 
of screening, for an individual woman it might offer a higher level of protection than 
an organized program because she might have more frequent screens, over a longer 
period of time, than that recommended in an organized program.  However this 
opportunistic benefit had to be balanced with the greater potential for harm, as the 
disadvantages of cervical cancer screening were both physical and psychosocial.  
Physical outcomes included complications, potentially unnecessary medical 
interventions, overtreatment, treatment costs, or delayed diagnosis from false negative 
test results; psychosocial outcomes include stigmatization, anxiety over false 
positives, and overtreatment for non-progressive abnormalities (International Agency 
for Research on Cancer, 2005).  
On the other hand, organized screening aimed for a population-level benefit 
that balanced benefits and harms, although in order to be cost-effective on a 
population basis this type of program might not offer an individual a screening test at 
a frequency that optimized her risk reduction (Anttila, et al., 2004; Miles, et al., 
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2004).  As shown in the chart below, epidemiological studies of effectiveness have 
enabled estimations of the impact of different screening intervals.  After the first 
screen, a second screen was usually recommended one year later to offset a potential 
false negative result.  After these two screens, reducing subsequent screens from one 
to three years only reduced the cumulative incidence of invasive cancer from 93% to 
91%.  This risk reduction might be acceptable on a population basis, but might not be 
ideal for a particular individual (Hakama, 1993; Goldie et al., 2005).   
Table 1: Protective effect of screening after a negative smear,  
ages 35-64 
 
Protective Effect of Screening After a Negative Smear 
Interval between  
screening (years) 
 
 
Reduction in  
cumulative Incidence of 
invasive cervical cancer (%) 
1  93.5 
2  92.5 
3  90.8 
5  83.6 
10  64.1 
 
Organized cervical screening programs have been shown to be effective and 
have been recommended by the World Health Organization (World Health 
Organization, 2010).   
 
Summary – Evidence for the effectiveness, efficiency and equity of organized 
screening programs 
The evidence indicated that the most effective, efficient and equitable cervical 
screening programs: targeted at-risk women; maximized participation of those 
women; utilized a strong quality assurance program; and used financial incentives to 
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limit opportunistic screening and thereby reduce overscreening.  Screening programs 
were typically classified as either organized, with a centralized invitation system at 
the population level, or opportunistic with screening initiated at the individual level.   
Organized cervical screening programs were the most likely to outperform 
opportunistic programs for equity, participation and cost effectiveness, while 
opportunistic programs were more likely to over-screen younger, affluent, lower-risk 
women and under-screen older, less affluent and higher-risk women.  Both types of 
programs could decrease incidence and mortality at the population level, while 
opportunistic programs might offer the most effective level of protection to the 
individual.  However, due to cytology‟s weaknesses as a screening tool, which could 
induce both physical harm from overtreatment, complications or delayed diagnosis, 
and psychosocial problems, such as anxiety and stigma, organized programs offered 
the most benefit and least harm at the population level.   
 
Determinants of cervical screening  
Global evidence 
In a 2005 IARC review of quantitative studies, most evidence of determinants 
of screening uptake was at the individual level.  There were numerous studies of the 
barriers to screening that were relatively consistent among women in different 
countries, such as studies that identified women‟s attendance for screening to be most 
negatively affected by her age, her lack of knowledge about the need for screening, 
her socio-economic position, and her marital status (Vellozzi, Romans & Rothenberg, 
1996; Eaker, et al., 2001; Blomberg, Ternestedt, Tomberg & Tishelman, 2008; 
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Paskett et al., 2009).  In particular, women aged 65 or older were more likely to report 
that their doctor did not order or recommend the screen, or that they did not know 
they needed a screen (Hewitt, Devesa & Breen, 2004; Waller, Bartoszek, Marlow & 
Wardle, 2009).  Studies also identified such psychosocial barriers as the women‟s 
perception of vulnerability, anxiety and fear of the cancer, her beliefs about the 
relevance of the test to her, and the priority she gave to screening (International 
Agency for Research on Cancer, 2005). 
 
Hong Kong evidence 
Several studies of Hong Kong women indicated that a similar range of factors 
contributed to the relatively high cervical cancer burden in Hong Kong.  In addition 
to similar demographic and socioeconomic factors, many women did not perceive the 
need for screening, did not know that the Pap test can prevent cervical cancer, and felt 
that the absence of symptoms negated the need for a check-up (Adab, 1999; Adab, 
McGhee, Yanova, Chin, Wong  &  Hedley, 2000; Chang  & Hazlett, 2002; Twinn, 
Holroyd, Fabrizio, Moore & Dickinson, 2005; Leung, 2010) 
Cultural factors were also barriers to screening.  Both cervical cancer in 
general, and HPV in particular, might violate cultural norms as they are associated 
with promiscuity and early onset of sexual activity (Kwan, et al., 2009).  Women 
cited concerns about modesty and embarrassment as barriers to screening, and other 
women saw cancer as fate, without much that one could do to prevent it (Holroyd, 
2004; Twinn et al., 2007).  In addition, screening may be associated with child-
bearing, as women described themselves as “too old” or that they “could not accept 
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the idea” of remaining at risk for cervical cancer.  One third of women between 50–
59 years of age had no intention of returning for further screening (Twinn, et al., 
2007). 
 
Physicians as facilitators to screening 
Physicians could facilitate women‟s decision to begin screening simply by 
recommending it opportunistically (Twinn, et al., 2007).  However, even after women 
decided to be screened, female practitioners could eliminate additional cultural 
concerns about male screeners.  Importantly, Twinn and Cheng (2000) found that 
women expressed little preference for a female nurse over male doctors, as long as 
the practitioner had experience and skills.  These necessary skills were defined as 
teaching, minimizing pain and discomfort during the test, and being considerate 
(Twinn & Cheng, 2000).  
 
Summary - Determinants of cervical screening  
Global evidence shows that women at the highest risk of dying from cervical 
cancer were older and had lower education and income.  Barriers to screening for 
women of all ages, albeit particularly for women most at-risk, included the lack of 
knowledge of and the need for screening, the perception of vulnerability, the priority 
given to screening, and the lack of a physician recommendation.  Hong Kong had a 
similar profile for high-risk women, and similar barriers to screening.  In addition 
there were culturally-specific concerns and a strong preference for female screeners.  
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Facilitators included recommendations from physicians, encouragement from family 
and friends, marriage, and the degree of other health-seeking behavior.  
 
Interventions to increase participation in screening 
Global evidence for interventions targeting physicians 
Consistent with the evidence that women cite a lack of a physician 
recommendation as a key facilitator to initiating cervical screening, interventions that 
targeted physicians have been shown to be effective in increasing uptake of cervical 
screening (Lomas, 1991; Grilli & Lomas, 1994; Snell & Buck, 1996).  While there is 
little evidence that passive dissemination of screening guidelines can influence 
physician behavior, evidence does indicate the effectiveness of guidelines that were 
easier to try, took account of local circumstances, were disseminated by active 
educational interventions and were implemented with patient-specific reminders 
(Lomas, 1991; Grilli &  Lomas, 1994; Stone, et al., 2002).  Snell and Buck (1996) 
studied provider “activation” methods both during and outside of the patient visit.  
During-visit interventions, such as reminders and flowcharts, helped to remedy 
physician forgetfulness in suggesting screening, while outside-visit interventions, 
such as education and audit with feedback, helped to update the physician‟s 
knowledge and correct overestimations of their actual performance in suggesting 
screening.   
Physician incentives were shown to be effective in increasing women‟s 
participation in screening.  England provided a compelling example of this 
intervention.  When physician incentives were added to other efforts done to create an 
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effective organized program in the 1990‟s, coverage rose from 42% to 85% from 
1990 to 1998, with over 90% of physicians reaching a target of over 80% of their 
patients screened (Patnick, 2000).  
Stone, et al. (2002) also found that targeting the physician at the environmental 
level was effective in increasing levels of preventive screening services.  In their 
meta-analysis they found that several organizational changes were effective: 
establishing a separate clinic devoted to screening and prevention activities, planning 
a visit specifically for preventive activities; using quality control or continuous 
quality-improvement techniques, and designating preventive responsibilities to a non-
physician staff.  In addition, health care provider reminders and educational outreach 
helped change provider behavior while less active interventions, such as attending 
conferences, reading medical journals or mailing clinical practice guidelines were not 
effective.  
 
Global evidence for interventions targeting women 
There was not a clear consensus about what worked to increase participation in 
screening.  Evidence included interventions that increased physician referrals and that 
addressed the lack of knowledge and psychosocial barriers(Giordano, 2009).  Letters 
to women were the most studied, because theoretically letters can address many of the 
barriers preventing women from attending for screening (Byles & Sanson-Fisher, 
1996).  If women were aware of the importance of screening, they might need a 
reminder when it was time to present for a screen, and a letter could serve as a prompt 
for that purpose.  If women did not understand the need for screening, letters could 
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emphasize the preventive role of Pap tests.  Letters could also educate women about 
screening, including the benefits and risks of the tests, and where to access the test.  
Personal invitations might also overcome barriers to women‟s perceived lack of risk 
to themselves (Byles & Sanson-Fisher, 1996).  Evidence also demonstrated that 
response rates rose when invitations were “sponsored” by a trusted or valued 
organization (Marcus & Crane, 1998).  Other evidence-based interventions included 
mass media campaigns, and outreach.  Mass media campaigns were successful, 
however they were expensive so typically media was only used for a short duration.  
However mass media was found to be most effective when used in combination with 
other outreach efforts, such as mailings or opportunistic screenings (Byles & Sanson-
Fisher, 1996). Outreach campaigns had some success when they aimed to make the 
message personal, such as using outreach workers, mobile vans, or personal appeals 
to family and friends (Marcus & Crane, 1998).  
 
Hong Kong evidence 
There is little evidence for interventions to increase the uptake of cervical 
screening in Hong Kong.  Health promotion campaigns could be effective, although 
they primarily served as a prompt for rescreening.  However there is no Hong Kong-
specific evidence for interventions targeting physicians, although women cited health 
care practitioners as an important source of information (Twinn, et al., 2007).    
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Summary - Interventions to increase participation in cancer screening 
Screening programs were directed at populations, yet they required individuals 
to accept the invitation.  These programs had the difficult task of encouraging women 
to present for a screen, and then to return for follow-up care if results are abnormal.  
Effective interventions to encourage screening addressed key barriers for the women, 
such as educational and psychosocial barriers, or addressed physicians as the 
gatekeeper and influential motivator.  No evidence indicated whether it was more 
effective to target physicians or women. 
 
III. Discussion 
Strength and weakness of studies  
The literature review is strengthened by the depth and breadth of the peer-
reviewed research done on cervical cancer screening, both in Western countries and 
in Hong Kong.  The evidence for organized screening programs and for determinants 
of screening was strong, and the Hong Kong evidence was similar to the Western 
literature.  However, aside from the evidence contributing to the elements of 
organized screening programs, such as population-based invitations, the evidence for 
interventions to increase the uptake of cervical screening was neither consistent nor 
comprehensive, with little research done on Hong Kong-specific interventions 
directed at physicians.  
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Implications for Hong Kong  
The evidence for an organized screening program‟s ability to reduce the 
incidence and mortality of cervical cancer is compelling and addresses the potential 
for Hong Kong to reduce outcomes in line with its level of economic development.  
Hong Kong women should benefit from the elements of organized screening that 
were included in the CSP, such as the recommended age and interval targets, the 
quality assurance, the capacity for follow-up and treatment, and the registry for 
surveillance and analysis.  However the CSP lacked key evidence-based program 
elements, such as interventions to increase provider screening recommendations; a 
comprehensive call-recall system; targeted interventions towards those most at risk; 
efforts to reduce inappropriate over-screening; and a referral system for abnormal 
tests.  Without specific, evidence-based efforts to overcome the barriers to screening, 
Hong Kong might find it difficult to realize its objective of the 80% participation 
necessary to achieve the desired population reductions in incidence and mortality for 
cervical cancer.  
 
IV.  Theoretical model of adoption 
Just as theories or models enhanced the effectiveness of interventions for 
cancer screening by guiding the complex practices of behavioral change at the 
individual level, theories could guide the adoption of an intervention at the 
organizational or settings level (Glasgow, Marcus, Bull & Wilson, 2004).  Everett 
Rogers‟ Diffusion of Innovations model (DOI) has been used to support the 
development of dissemination programs, and to analyze the transfer process (Finney 
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Rutten, Nelson, Meissner, 2003; Prochaska, Fromont, Suchanek, Hudmon & Cataldo, 
2009). Rogers‟ defined dissemination as the “planned process of creating awareness 
of the program or interventions among the targeted population, informing 
stakeholders about the innovation and persuading them to try it” (Rogers, 2003). 
Rogers defined four main elements involved in the Diffusion of Innovation, 
where diffusion was the “process by which: a) an innovation; b) was communicated 
through certain channels;  c) over time; d) among the members of a social system” 
(Rogers, 2003).  
All innovations are not equivalent, and their characteristics influenced their 
rates of adoption.  Relative advantage was the degree to which an innovation is 
perceived to be better than the previous idea.  Perception of advantage, which can be 
influenced by economics, social prestige, convenience, or satisfaction, was more 
important than objective metrics.  Compatibility was the degree to which the 
innovation was perceived to be consistent with the potential adopters‟ past 
experiences, current values and future needs.  Trialability was the degree to which an 
innovation might be experimented with, without permanent commitment, so that it 
was less risky.  Observability was the degree to which the result of an innovation 
could be seen by others, thereby stimulating peer discussion and allowing others to 
observe the experience.  Finally, complexity was the degree to which an innovation 
was perceived as difficult to understand and difficult to use.  Higher levels of relative 
advantage, compatibility, trialability and observability, and lower levels of 
complexity, drove adoption more rapidly.  
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Innovations depended upon the communication channels to be spread; 
Rogers‟ defined a communication channel as “the means by which messages get from 
one individual to another” (Rogers, 2003).  Communication channels could range 
along a continuum from mass media, which was an efficient way to increase 
awareness and knowledge of an innovation, to interpersonal channels for direct 
communication.  Among the types of interpersonal communication, people were most 
likely to accept an innovation from someone most like herself.   
This decision process involved knowledge, the step of becoming aware of and 
learning about the innovation; persuasion, the formation of a favorable or unfavorable 
attitude about the innovation; the actual decision, the choice the person made about 
the innovation; implementation, putting the innovation into use; and confirmation, 
seeking reinforcement about the adoption decision with the potential to reverse the 
first decision.  At the end of this decision process the person might decide either to 
adopt or to reject the innovation. 
The last element of the diffusion adoption model was the social system, defined 
as “a set of interrelated units that are engaged in joint problem-solving to accomplish 
a common goal” (Rogers, 2003).  Certain types of individuals influenced diffusion 
into the system more than others: opinion leaders, who derived their status 
unofficially through technical competence, social accessibility and conformity to the 
system‟s norms; and change agents, who were professionals who represented change 
agencies outside the system. Importantly, both types of individuals could serve to 
facilitate innovation, or to slow it down or prevent it.  
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V.  Implications for research 
This literature review identified the opportunity for an organized screening 
program to effectively, efficiently and equitably reduce the incidence and mortality of 
cervical cancer.  The literature also identified the key determinants of cancer 
screening, and demonstrated that effective interventions to increase the uptake of 
screening included increasing physician referrals.  The importance of the physician‟s 
role in encouraging the uptake of screening contrasts with the low rates of physician 
participation in Hong Kong‟s CSP.  This gap highlights the need to understand factors 
influencing the physician‟ participation in the CSP.  Rogers‟ Diffusion of Innovation 
proposes a framework for studying the dissemination of an innovation, such as the 
CSP.  Therefore, the study will utilize the concept of “adoption” and its components 
as the theoretical framework to study the physicians‟ participation in the CSP. 
 
 
 
  
 
 
 
CHAPTER 3 
METHODS 
 
The literature identified the crucial role of physicians in encouraging the uptake 
of screening, which led to this study‟s focus on enrolling physicians in the CSP.  This 
chapter delineates the methods used to study the factors influencing the physicians‟ 
participation in the CSP.  The chapter presents the major components of the 
discussion guide, and discusses the changes made following pilot testing.  Next, it 
reviews the sampling strategy and analyzes the resulting study sample.  The chapter 
also discusses the data analysis, including the coding and the qualitative analysis 
procedures.  The chapter concludes with a discussion of efforts to increase study 
validity and reliability, as well as the limitations of the study.   
 
I. Study Design 
Sixteen key informant interviews with physicians were conducted in Hong 
Kong over the period of January to March 2011.  The objective of the interviews 
was to explore the factors that have, or might, influence their decision to participate 
in the CSP.  Rogers‟ Diffusion of Innovations, and its focus on the individual‟s 
adoption-decision process, served as a theoretical framework for analysis.  The 
interviews explored such factors as the physician‟s perception of the characteristics 
of the program, their communication channels, and their innovation-decision 
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process.  Physicians, whether familiar with the CSP or not, were given a description 
of the program to read before the discussion (CSP Description is found in Appendix 
C).   
 
Discussion guide pilot testing 
The Discussion Guide was pilot tested with two physicians; one was a 
member of the original Cervical Screening Task Force, and one was in private 
practice.  They were a convenience sample chosen either for their knowledge of the 
program or for their experience as a private practitioner, respectively. Both 
physicians had difficulty answering theoretical questions about their adoption-
decision process so it became necessary to develop and include questions about 
actual innovations that were familiar to them.  After some trial and discussion, two 
innovations were identified that would provide appropriate insights into the 
physicians‟ decision process: a government flu vaccine voucher program, or more 
commonly known in Hong Kong as a scheme, and the HPV vaccine.   
The government‟s flu vaccination scheme, introduced in 2009, offered 
people over 65 years of age a HK$50 voucher (about US$8) to offset the cost of a 
flu shot at a private physician‟s office.  Most private physicians who were General 
Practitioners (GPs) and Family Practitioners (FPs) joined the scheme.  The program 
required physicians to register with the government, and to perform certain 
administrative tasks for accounting purposes, such as recording the patient‟s 
identifying data, and checking the availability of the voucher online.  The 
program‟s characteristics were similar in many ways to the CSP: it was a 
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government program; it applied to a large percentage of the population; it was 
computer-based; it required the patient and the physician both to register; and it was 
introduced to the target populations in a similar manner.  However, unlike the CSP, 
the flu vaccine offered a financial subsidy to the patient that they could apply 
toward the provider of their choice.   
The second alternative innovation was the HPV vaccine.  OB/GYNs did not 
provide general patient care, so the HPV vaccine was more appropriate for these 
specialists.  The key similarity with the CSP was that the vaccine was also 
associated with cervical cancer, and therefore was likely to have similar cultural 
associations with promiscuity and premarital sexual activity.  The differences 
between the HPV vaccine and the CSP related to their source and their method of 
introduction: the HPV vaccine was offered by private pharmaceutical companies, 
and the companies‟ promotional efforts were well-funded, highly-visible, and 
memorable (See Appendix B for the Discussion Guide for Key Informants). 
 
II. Participant Selection 
Sampling frame 
Cervical screening rates can be influenced either directly, by attempting to 
change the behavior of the women, or indirectly, by working with physicians to 
recommend screening to their patients.  This study focused on the physicians‟ role, 
so the unit of analysis was the physician.   
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Sampling strategy 
The sampling strategy utilized both snowball sampling, after the initial 
referrals from the physicians‟ association leaders and HKU School of Public Health 
(SPH) professors; and purposeful sampling, to include a representative mix of 
genders, specialties, districts and CSP-registered physicians.  This sampling was 
more difficult than anticipated, as only about half of the physicians interviewed 
were willing or able to recommend a colleague to interview.  In an effort to recruit 
additional physicians in different districts, particularly more men, two physicians 
were recruited by “cold calling” physicians on an insurance directory listing.  
Additionally, three physician leaders were interviewed to explore their perceptions 
of their association members, as well as their own experiences with the CSP. 
It was originally proposed that interviews be limited to private physicians, 
however as the data emerged it became necessary to understand the perspective of 
those who had adopted and used the CSP.  In this sample, too few private 
practitioners knew enough about the program, due to limited registration with the 
program.  Therefore, the sample was broadened to include three physicians who 
were in a government or NGO multi-center clinic setting (“clinic-based” 
physicians), that were registered with the program as a matter of organizational 
policy.  
Recruiting was conducted either by telephone or email, depending on the 
contact information given.  Once the physician agreed to be interviewed, the date 
and time were scheduled at their convenience and in a venue when she/he could 
speak confidentially.  All interviews except one were conducted in the physician‟s 
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office; that interview was conducted in a public restaurant.  Consistent with the IRB 
approval, written consent was obtained prior to the interview. 
 
Description of key informant sample 
Twenty-nine physicians were approached for an interview, either via email 
or phone, and sixteen physicians accepted, for a response rate of 55%.  This 
response rate was relatively low, given that most physicians contacted were 
personal referrals.  Twelve respondents (69%) were female and four (31%) were 
male.  For perspective, over 70% of physicians in Hong Kong are estimated to be 
male (Medical Council of Hong Kong, Li, 2003).   
The preponderance of female key informants was the result of a 
disproportionate number of female physicians referred during the recruitment 
process, as well as a significant difference between response rates for female versus 
male physicians.  During the snowball sampling, when key informants were asked 
to refer additional physicians for potential participation, they were more likely to 
suggest female physicians, even when specifically asked for males.  When this 
gender bias was detected, the personal referrals were supplemented with cold calls 
from a local insurance company‟s listing; however due to the underlying male-
female physician ratio, four of the five names randomly selected were male.  In 
addition, there was a marked difference in male and female response rates: 67% of 
female physicians agreed to join the study (12 of 18 approached), while only 36% 
of male physicians agreed to join (4 of 11 approached).  These differing response 
rates held for the physicians from the insurance listing; only one of the four male 
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physicians randomly contacted agreed to join the study, while the only female 
contacted also accepted.   
Among the key informants, there was a mix of specialties, type and size of 
practice, and districts (Table 2: Key Informant Characteristics).  Seven (44%) of the 
physicians were in Family Practice (FP), six (38%) were in General Practice (GP), 
two (13%) were OB/GYNs (GYN) and one (6%) was an Estate Doctor (ED).  In 
terms of size of their practices, about six were in solo practice (38%); five practiced 
in small groups of six or less (31%); while the remaining five (31%) worked for 
government or large multi-site practices.  The key informants had a range of 
experience, with the newest physician having only six years experience, about half 
with 10–20 years experience, and a few with over 25 years of experience.  The 
sample was geographically heterogeneous, as the sixteen physicians worked in 
twelve different districts in Hong Kong.  The districts reflected the economic 
distribution of Hong Kong‟s population, with the majority of the physicians 
working in middle income districts, a few in low-income districts and a few in the 
business district of Hong Kong, which had the wealthiest patient base.  The 
majority of physicians had trained in Hong Kong, although two had trained in the 
U.K. and one in Australia.  Most of the GP and FP physicians estimated that a 
majority of their patients were women, with percentage estimates ranging from 60–
75%.  The OB/GYNs and physicians practicing in “Well Women” clinics had 
female patients exclusively.   
Physicians were also asked about the importance of cervical screening as a 
preventive practice:  “On a scale of 1 to 10, with 1 „not at all important,‟ and 10 
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„most important,‟ how important is cervical screening to you as a preventive 
practice?”  All physicians rated cervical screening in the range from 7–10, with 
over seven of the sixteen physicians giving it the highest rating of 10. 
 
 
  
 
 Table 2: Key Informant Characteristics 
Spe-
ciality Sex District 
Reg’d
a
 
Train 
in 
HK 
Type of 
Practice 
Patient 
Income 
Level
b
 
Imp 
of 
CS
c
 
Screens 
per 
month
d
 
Reminder 
System
e
 
FP M Central Yes Y Solo Mid 9 30 Yes 
OB/GYN F Mongkok Yes Y 2 GYNs Mid 8 50-60 Yes 
FP F Quarry Bay Yes Y 4 FP/GP‟s Mid 8 5-6 No 
FP F Jordan Yes Y Clinic-based Mid 10 100 Yes 
FP F Jordan Yes Y Clinic-based Mid 9-10 100 Yes 
FP F Wan Chai Yes Y Clinic-based Low-Mid 10 60 Sometimes 
ED M Hong Hum No Y Estate Mid-Low 7 None No 
GP 
F Aberdeen No Y Clinic-based Mid-Low 10 None No 
GP M Mei Foo No Aust Solo Mid 10 3-4 Yes 
OB/GYN F Mongkok No Y 2 GYNs Mid 8 50-60 Yes 
FP F Central No UK Solo High 10 20-30 Yes 
GP F Ap Lei Chau No Y Clinic-based Low 9 5-6 No 
FP F Central No Y 
3 GPs,  
2 GYNs High 9 30 Paper 
GP / 
Resp M Chai Wan No Y Solo Mid-High 10 1-3/year No 
GP F 
Chi Fu / 
Central No 
HK/ 
UK 
Solo, 
2 Venues Mid 10 10 Paper 
GP F Kung Tung No Aust 3 GP‟s,  Mid-High 9-10 100 File Note 
a Reg‟d: Is the physician registered with the CSP? (Responses: Yes or No). bPatient Income Level: What is the general economic level of patients in the physicians‟ 
practice (Responses: High, Medium or Low). cImportance of CS: Physicians were asked: “On a scale of 1 to 10, with 1 „not at all important,‟ and 10 „most important,‟ 
how important is cervical screening to you as a preventive practice? ” dScreens per month: How many cervical screens did a physician conduct per month, regardless of 
their participation in the CSP. eReminder system: Did the physicians have a reminder system, and if so, was it electronic or another type?
4
1
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III. Data Analysis: 
Coding 
Coding and analysis was conducted with Dedoose, a Macintosh-compatible, 
web-based application, that could be used for qualitative and mixed methods 
research (Lieber & Weisner, 2010).  The transcripts were imported into the 
software, where the interviews were coded.  The software was used for data 
retrieval, sorting, analysis, and output for data matrices.   
Rogers‟ theoretical framework provided the conceptual structure for many of 
the codes, a priori.  The aim was to define the codes so as to be “clear, operational 
and reliably usable” (Miles & Huberman, 1994, p. 63).  After about one-third of the 
transcripts were coded, the codes were checked against the earlier coding, and 
further clarification of the decision rules was made.  In addition, during the coding 
process, patterns or themes emerged that were not covered by the first set of 
descriptive codes, so two further thematic codes were added: “framing the 
physicians‟ practice as a business (business framework),” and “the physicians‟ 
perceptions of women‟s knowledge, attitudes and practices (KAP).”  (For further 
details see Appendix D for the Code Book). 
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Data Management 
Each physician was assigned a unique numerical code, in order to maintain 
the confidentiality of the data.  This numerical code was used on the physician‟s 
tape recordings, data analysis and data summaries.  The interviews were double-
taped and verbatim transcripts were made.  The tapes were kept in a locked safe and 
files were password protected on a home computer.  When the transcripts were 
received, random key sections of the tapes were listened to again and crosschecked 
in order to increase reliability.  
 
Analysis 
Within one day of each interview, field notes that included overall 
impressions were written, including but not limited to key information according to 
each element of the theoretical framework, reflections on potential themes, and 
suggestions for future interviews. 
During analysis the individual physician interview field notes were further 
consulted, and the transcripts were reread when needed for additional clarification.  
Matrix displays for themes and higher-level analysis were created.  Data were 
entered into the matrices, first with supporting quotes, and then summarized into 
higher-level matrices.  Data were analyzed first by comparing specialty, second, by 
comparing gender, and then by other potentially differentiating factors.  Data were 
then sorted into two groups by registration status: the physicians registered with the 
program Reg), or physicians not registered with the program (NR).  Within the 
group of those who were registered, data were also analyzed by those in private 
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practice versus those who were in government or large NGO clinic settings.  
 The most relevant matrices were organized into findings, then supported and 
illustrated by citations from the underlying transcripts. These quotes were then used 
in the Results chapter.  Given that many of the physicians were non-native English 
speakers, some quotes were edited (noted in brackets) to correct the grammar and 
convey the content of the quote, although efforts were made to preserve the key 
informants‟ voice. 
Also in the dissertation, quotes were identified with key physician descriptors 
where pertinent, such as registration status, specialty, size of practice, gender, etc.  
However, the descriptive data were omitted when such data would potentially 
identify the speaker, typically for gender or specialty descriptors. Each quote was 
also labeled with its numerical physician code, which helped illustrate the 
frequency of any individual physician‟s quotes.  In order to verify the analytic 
conclusions, the following processes were used: 
 Validity:  Various methods were employed to improve validity (Mays &  
Pope, 2000). First, summaries of the physicians‟ perceptions of the CSP 
characteristics were examined for discrepant viewpoints.  Then results were 
triangulated between different data sources to explore them further.  
Discrepancies were most frequently explored between physicians with 
different registration status (registered versus non-registered), different 
specialties, and finally different genders.  The triangulation assisted in 
determining the validity of the perspectives.  Quotes were used to demonstrate 
the underlying information and to present discrepant information.  Finally, 
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reflexivity was considered, using quotes to help clarify any existing biases.  
Attention was paid to negative cases and considerable effort was spent 
illuminating the issues.   
 Reliability: In order to increase study reliability, all of the interviews were 
double-taped, the transcripts were re-checked against the audio tape and post-
interview contact summary notes as they were coded, and further attention to 
potential code “drift” was paid.  Early in the coding process the code 
definitions were re-evaluated and subsequently five of the initial interviews 
were re-coded.  Finally, a log of the data management and analytic methods 
was developed so as to document research activity. 
 
IV.  Limitations:  
A)   The sampling frame was adapted to accommodate the scarcity of private 
physicians who were both registered and active in the program, as documented 
above.  Only three private physicians had registered with the program and 
therefore had personal knowledge of the program‟s actual benefits and barriers, 
which might limit the generalizability of this research to other private 
physicians.  However, the three physicians‟ data were consistent with the data 
from the private physicians who knew of the program yet had not registered, 
and with the clinic-based physicians who had registered with the program. 
B) The relatively high participation of physicians with higher professional 
qualifications, such as specialties in Family Practice (FP) or Gynecology 
(GYN),might limit the generalizability of the findings to the majority of the 
physician population who do not have advanced qualifications.  However, 
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results between those private physicians with advanced qualifications and those 
without were generally similar. 
C) The relatively low response rate, 55%, might also limit the generalizability of 
the results.  Other than under-participation by male physicians (30% of key 
informants versus 72% of Hong Kong practitioners) the background and 
attitudes of the non-responders were not known.  These non-responders might 
have different viewpoints about cervical screening, and about the CSP.  Two 
indications of this potential bias were that most physicians responded 
genuinely positively to the question on the importance of screening as a 
preventive care measure, and that most of the physicians interviewed stated 
that they often suggested screening to their patients.  These responses are not 
consistent with screening rates in Hong Kong.  However, given that these 
attitudes were almost universal among the key informants interviewed, the 
finding might be indicative of attitudes, and not practices, among the larger 
physician population.   
This chapter summarized the methods used in this qualitative study of physicians‟ 
attitudes on the CSP.  It discussed evolutions in the discussion guide and the sampling 
strategy that evolved as the data emerged, and it delineated the data management and data 
analysis process.  It also discussed efforts to increase study validity and reliability, and the 
potential limitations to the study design.  The next chapter presents the results of the study, 
organized by the key findings, and illustrated with key informant quotes.  These results will 
then be utilized to inform the Plan for Change. 
 
  
 
 
 
 
 
CHAPTER 4 
 
RESULTS 
 
This chapter reports results of key informant interviews that examined factors 
influencing private physicians‟ under-participation in the CSP, using the methods defined in 
the previous chapter.  The factors that were studied draw upon Rogers‟ theoretical framework 
of the Diffusion of Innovations.  These findings report physicians‟ perceptions of the 
characteristics of the CSP; what communication channels might influence adoption; and what 
the physician‟s adoption-decision process was for their practice.  However, as discussed in 
the Methods section, few physicians knew about the CSP and physicians had a difficult time 
responding to hypothetical questions about adopting a new program into their practice; 
therefore physicians were also asked to consider adoption issues in the context of the 
government-sponsored flu vaccine voucher, or the HPV vaccine. 
During the analysis, three physician perspectives on innovation decisions emerged: (1) 
a business perspective; (2) a patient perspective; and (3) a public health perspective.  The 
business perspective was most common, as physicians reported a need to ensure the financial 
success of their practices.  As discussed in more detail in the following findings, this business 
framework was evidenced primarily in physicians‟ discussions of the “cost” of doing 
business and their reluctance to reduce the frequency of patient screens.  Other times the 
physicians took their patient‟s perspective as they talked about such patient concerns as their 
desire for a female screener.  Finally, from a public health perspective, the physicians 
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sometimes took a broader view of their role and spoke about the public health aspects of the 
innovations and their own contribution to said public health in Hong Kong.  Aspects of these 
perspectives will be presented and discussed in the relevant findings, and summarized in 
Table 3 below.   
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Table 3: Research Key Findings Summary 
 
Research Key Findings Summary 
Finding 
#1 
Physicians perceived that the CSP‟s benefits were rarely meaningful to 
their practice (Relative advantage) 
 
Finding 
#2 
Many physicians perceived the CSP as time-consuming and 
administratively problematic (Complexity) 
 
Finding 
#3 
Many physicians found the CSP to be inconsistent with their perception 
of the women‟s cervical screening Knowledge, Attitudes and Practices 
(KAP) and their typical patient care practices (Compatibility) 
 
Finding 
#4 
Most physicians typically learned about potentially applicable 
innovations through relatively passive communication channels 
 
Finding 
#5 
Physicians tended to make rapid decisions about new programs, without 
much time for consideration, trial or consultation with others 
 
 
 
 
Key Finding #1: Physicians perceived that the CSP’s benefits were rarely 
meaningful to their practice (relative advantage) 
 
After reading the description of the CSP that highlighted the program benefits, a few 
physicians could not identify any pertinent benefit.  Most physicians identified the 
recall system and the online screening history as the most important benefits; however, 
these benefits were not substantially better than the status quo of their current 
practices. 
 
 
Perceived lack of benefits 
A few physicians, after reading the description of the CSP, were unable to 
identify any perceived benefits of the program.  One physician expressed this clearly: 
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“I don‟t think that there is a need for it here; it wouldn‟t add any value to the way we 
practice now (110322, Non-registered, GP, small group).” 
 
Registry recall and reminder system: 
 
Most physicians identified the program‟s recall system as the most pertinent 
benefit of the program, although most physicians that performed even a minimal 
number of Pap tests (over 10 screens a month) found this benefit to be redundant to 
their own practice system.  Physicians‟ recall systems ranged from sophisticated 
computer programs that sent automatic patient reminders, to penciled notations in a 
patient‟s file that the doctor would check during a patient visit.  Most physicians 
concurred that a patient recall system should be an essential component of any general 
practice that conducts cervical screening, as shown in this quote: 
If the physicians don‟t recall the women, the women won‟t come back.  The 
physicians will lose the business, right?  That is why in that sense the Registry 
is of limited help to one‟s practice.  You either determine to do this kind of 
screening and you would have your own system to make sure this follow-up 
happens, or basically this is not something that is a high priority in your 
practice (110104, Registered, FP). 
 
Some physicians optimistically perceived that the recall system might increase 
their business, although this perception was only expressed by non-registered 
physicians.  This physician, quoted talking about potential demand from the program, 
did not conduct many cervical screens: 
If I join the program probably more female patients may come here for regular 
cervical screening (110323, Male, Non-registered, GP). 
 
 
  
51 
 
Online access to patient data 
Physicians differed in their assessment of whether the online screening history 
was a benefit to them.  Naturally physicians preferred to have access to their patient‟s 
past screening results, as it would help improve patient care: 
Access to the client‟s smear results online, I think, is good.  Actually we can 
know the result distributed online and we can….have a thorough understanding 
of the condition. I think that is good (110113, Non-registered, GP). 
 
 
However, many physicians perceived the online results to be unnecessary, as 
physicians kept their regular patients‟ past records in their files and new patients 
generally knew a sufficient amount about their past screening results for the physician 
to determine their clinical history.  This quote illustrates the physician‟s determination 
of a patient‟s past screening results: 
Pap smear results are simple.  The patient will know if her past result is normal 
negative, or if there is something abnormal that [requires] some follow-up 
afterward….So the information is already adequate (110301-02, Non-
registered, GYN). 
 
 
Five of the six registered physicians interviewed did not perceive any benefits 
from the CSP.  When asked about the benefits of the program, these physicians 
reported the same reactions as the non-registered physicians: the recall system and 
online access were redundant. 
In contrast to the CSP‟s inability to add value by increasing patient demand, the 
flu voucher was perceived as contributing to the physicians‟ practices.  The flu 
scheme was a subsidy for the patients to be used with any provider, so physicians 
reported competitive pressure to join the scheme.  This physician‟s response is typical 
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of the physicians that joined the flu scheme because their patients requested their 
participation: 
Why did I participate?  I have lots of patients enrolled.  So I think that it‟s 
providing an extra service to my patients…a lot of patients…a lot more than 
from the cervical screening [program] (110309, Registered, GP). 
 
 
This physician reported how the flu scheme increased her patient revenue: 
Why did I join the flu scheme instead of [the] CSP?  Because I get revenue from 
it (110330-01, Not-registered, FP, private). 
 
 
Summary  
The CSP‟s primary benefits were not salient to physicians‟ practices as they were 
usually duplicative to existing processes or capabilities.  Physicians identified the 
CSP‟s recall and reminder system as a benefit.  However, most physicians who 
conducted cervical screening already had some type of recall system; therefore the 
system was not advantageous to their current practice.  The online screening history 
feature was also not important, as most physicians would work with the women to 
determine her past screening history.  Importantly, after joining the CSP, only one of 
the six registered physicians perceived the program to have any meaningful benefit 
for his/her practice.  In contrast, the flu vaccine‟s strong patient demand was a unique 
benefit to their current practice, and resulted in almost universal adoption of that 
scheme. 
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Key Finding #2: Many physicians perceived the CSP as time-consuming and 
administratively problematic (complexity) 
 
Most physicians perceived the program‟s administrative process to be complex 
and time-consuming.  Often the program‟s complexities impacted physicians‟ practice 
costs or revenues.  Some physicians also characterized the administrative demands as a 
distraction from patient care.  However, some physicians, including a few private and 
all the clinic-based physicians, found the program‟s complexity to be manageable, and 
therefore not a barrier to adoption. 
 
Administrative demands 
Many physicians were concerned about the perceived time and effort required to 
use the system.  Some physicians performed the administrative work themselves, and 
they reported this time as a barrier to enrollment: 
Doctors may skip the stuff that requires time since there is a time constraint in 
consultation (110315, Non-registered, GP). 
 
 
Physicians shared their concerns that complexities of the program would result in 
lost time and revenue.  One physician stated that, in the time it would take to conduct a 
screen and then complete the administrative process, the program “…. would lose 
business for me” (110307, Non-registered, FP).  Another physician highlighted the 
opportunity cost of doing the administrative work: “It only takes five minutes [to 
screen], but in five minutes they can see another patient (110114, Non-registered, FP, 
private). 
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Cost concerns 
Discussions of the flu scheme helped illuminate the business costs of the 
administration.  Physicians talked about the time that program required to train their 
staff, and they complained that the program was too complicated to administer on an 
on-going basis: 
Having said that, it is actually costing me time, from the difficult workload and 
so on and so forth, to actually make it work in a private practice like this 
(110323, Non-registered, GP).  
 
In addition, sometimes the paperwork was incorrect so the physicians did not receive 
payment: 
Well, it [administration]is complicated.  Trying to explain to the patients what 
to sign; filling in all the forms; sending them in.  If you are late you don‟t get 
paid.  If the patient signs the wrong thing, you don‟t get paid.  And you end up 
losing money.  The patient never comes back to pay (110225, Non-registered, 
GP). 
 
 
When questioned about the perceived administrative demands of the CSP versus the 
flu scheme, one registered FP (110225) said succinctly: “Similar. Just as bad.”   
Among the registered physicians, the private physicians were less tolerant of 
the complexities of the program.  In this representative quote, a private physician 
expressed exasperation at the time and effort required to administer the program: 
I am registered.  But then I have so many problems getting onto it, really!  The 
first few times I couldn‟t get on the computer.  The website is really not well 
done.  I mean, honestly, the website is a deterrent for practitioners to join 
(110104, Registered, FP, private). 
 
In contrast, a few of the private physicians and all the clinic-based physicians 
perceived the CSP administrative demands to be relatively few, as their staff support 
protected them from the administrative burden.  One physician‟s quote acknowledged 
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the shift in the burden: “For me it‟s simple, because most of the things are done by the 
clinic assistant” (110309, Registered, FP, clinic-based).   
 
Summary  
The CSP was perceived to be problematically complex.  Physicians placed 
differing levels of importance on the CSP‟s complexity as a barrier to enrollment 
depending on the degree to which their administrative staff could manage the work.  
For those few physicians that had the administrative capability, this complexity was 
not much of a problem, however most physicians had minimal staff capability, or 
limited time and interest to do the work themselves.  In the US, the perceived 
complexities of the CSP and flu vaccine might be similar to physicians‟ experience 
with insurance paperwork and approvals. However in Hong Kong most primary care 
patients are self-pay, so consequently physicians are unused to these types of 
administrative demands. 
Key Finding #3: Many physicians foundthe CSP to be inconsistent with their 
perception of the women’s cervical screening Knowledge, Attitudes and Practices 
(KAP) and their typical patient care practices (compatibility) 
 
All the physicians interviewed stated their belief that cervical screening was 
perhaps the most important preventive care service, and most of the physicians 
interviewed said that they often raised the issue with their patients.  However, as 
described below, the CSP‟s objective of increasing recommendations for cervical 
screening conflicted with the physicians‟ perceptions of women‟s KAPs about 
screening.  In addition, the physicians also raised business concerns about the CSP‟s 
compatibility with their preferred patient care practices. 
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KAP: knowledge of cervical screening 
Many physicians felt the CSP was not compatible with their practice because 
their patient population was not knowledgeable about cervical screening.  Physicians 
were reluctant to spend time educating and motivating their patients.  This knowledge 
gap was particularly significant for physicians with patients of lower socioeconomic 
background or those in general practice: 
We have a lot more women with whom you would have to reach out to initiate 
screening, because they don‟t have very much knowledge about it.  With the 
local population, if they don‟t feel that they have anything wrong with them, 
then they don‟t feel the need to do screening.  They really don‟t.  The whole 
concept of this kind of preventive screening is not very well established in the 
local Chinese population.  They are very inactive rather than proactive (110322, 
Non-registered, GP, when working previously in low income practice area). 
 
Conversely, this same physician who moved to a relatively high socioeconomic 
district, subsequently perceived that her new patients had a sufficient knowledge of 
cervical screening: 
The knowledge of screening here is extremely high and we really don‟t have to 
reach out to people to encourage them to have screens.  They initiate a lot of it.  
It‟s seldom that we have to encourage someone to do it who hasn‟t done it 
before  (110322, Non-registered, GP, when working in high income practice 
area). 
 
 
 In addition, some physicians had experienced a gradual increase in their 
patient‟s awareness and acceptance of cervical screening over time.  This increase was 
most pronounced among the physicians who trained overseas in countries with strong 
preventive screening practices.  In the quote below, this physician explained the 
differences shehad observed in herpatients over times: 
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I came back straight from the UK…I was wondering why on earth these people 
do not want to have Pap smears done.  I thought it was Chinese culture.  At first 
it was an uphill climb for me to explain.  I‟ve even made up leaflets.  I have 
been giving them out like anything…But after ten years now I hardly need to 
give any one of these leaflets to any patients; I mean I will if they are very 
ignorant, but I found they are asking for it rather than me having to ask them for 
it.  I think the knowledge base has grown.  People have heard about it. I think 
this has become the norm (110307, Non-registered, FP, relatively high income 
practice area). 
 
 
Physicians also perceived that age was a barrier to cervical screening; 
physicians observed that women over 55 years were not as aware of the need for 
cervical screening as younger women: 
With older Chinese women, their lack of knowledge is a little bit of a barrier to 
doing this kind of screening (110322, Non-registered, GP). 
 
 
Also age-related physical problems made screening uncomfortable: 
 
Getting to post-menopausal women is very difficult because physically it‟s a 
very uncomfortable examination to have post-menopause and it really is hard 
getting them to do that.  I mean it‟s not a comfortable procedure and so you 
really need to sort of reassure them that this is necessary.  And that‟s really hard 
because they feel fine and they don‟t see the need for it  (110322, Non-
registered, GP). 
 
Importantly, the HPV vaccine provided some insights for the CSP.  Physicians 
reported that most of their patients were not aware of, or knowledgeable about, the 
HPV vaccine, analogous to their lack of knowledge of the Pap test.  Yet the physicians 
were gradually able to motivate their patient to have the vaccine.  In the following 
quote, a GYN shared her experience introducing patients to the HPV vaccine: 
[The HPV vaccine and the Pap test] are similar because people are coming in 
for a check-up, and then you introduce them to the vaccine.  Sometimes the 
patient will have the first injection at the same appointment or sometimes they 
will think about it.  And then they call back, “I want the vaccine.” And then 
because it just takes a few minutes, they just come in, get an injection, and I get 
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them out.  So there won‟t be any inconvenience (110301-02, Non-registered, 
GYN). 
 
 
KAP: Screening link with promiscuous behavior 
A few physicians expressed the concern that women were reluctant to undergo cervical 
screening because they associated it with promiscuous behavior.  This quote 
demonstrates the perception of this cultural barrier to screening:  
I think the whole cultural thing in Hong Kong is a big thing.  Basically women 
don‟t really understand why they are having the test; what does it mean when 
they have the test; what does the result mean?  A lot of people think that by 
admitting they have had a cervical screen, they admit that they are promiscuous.  
That kind of thinking is still really prevalent so there are lots of barriers to 
overcome (110315, Female, Non-registered, GP). 
 
 
KAP: Preference for a female physician 
Most physicians attempted to increase screening among their patients.  However 
many of the male physicians were unsuccessful because their patients preferred to be 
screened by female practitioners.  One physician shared his experience: 
The female patients told me that usually they will find female doctors to 
perform this kind of screening.  Very rarely they will find a male doctor 
(110315, Male, Non-registered, GP). 
 
 
Another physician had restricted himself to reminding women to be screened, rather 
than suggest that he perform the screen himself: 
Some patients prefer female practitioners.  They are just not comfortable with a 
male doctor.  So for these patients I would not insist.  But I will always remind 
them to make sure they do have a gynecological checkup with a Pap smear 
every two years (110104, Male, Registered, FP). 
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Female physicians agreed that women preferred a female screener: 
Even if a [male] GP suggests cervical screening they would say: “I want a 
female.”  And we have more male doctors in Hong Kong anyway (11301-02, 
Female, Non-registered, GYN). 
 
This physician related that women‟s preferences for female providers were so strong 
that the women would even change providers rather than be examined by a man: 
I think women actually prefer to be seen by a woman doctor.  Yes, some people 
even change the doctor, just because of the gender of the doctor (110301-01, 
Female, Registered, GP). 
 
This physician conjectured that, during a gynecological exam, both the female patient 
and the male physician were embarrassed, and therefore the exam was not thorough: 
I think it‟s mostly just less embarrass[ing], because they don‟t want to be seen 
or touched by men….many patients tell me that when they do a Well Woman 
checkup… if they are examined by a male doctor, they are embarrassed.  And 
then the doctor seems to be embarrassed, too.  They just do it[the exam] very 
quickly, you know.  They just think it is too embarrassing (110325-01, Female, 
Registered, FP). 
 
 
KAP: Preference for specialist  
Physicians perceived that women would prefer to visit a gynecologist, rather than a 
GP.  Physicians reported that many women believed that only specialists could 
perform cervical screening: 
Usually in Hong Kong, I‟ll say, not many women would go to a general 
practitioner for screening.  They want a gynecologist.  And the women [female 
gynecologists] would be the more popular, so there‟s quite a lot of people that 
just phone in to make an appointment….just for screening (110301-02, Female, 
Non-registered, GYN). 
 
But it is interesting sometimes women from North America come here and they 
have the funny idea that only gynecologists are capable or experienced enough 
to take a Pap smear.  So it seems interesting that women from North America 
have got this idea that family physicians can‟t do Pap smears or Gynie check-
ups or anything like that.  So initially they say: “Do I need to see a gynecologist 
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to have a Pap smear?”  [I reply]“No, of course you don‟t (110322, Female, Non-
Registered, FP).”  
 
Physicians also reported that some women would not consider having a cervical 
screen with the same doctor they consult for medical problems.   
Some people ask me, “I want to have a cervical screen.  Can you introduce a 
specialist gynecologist for me?”  And they have not thought of their GP, the one 
who would be seeing their common cold or joint paint or toothache for them.  I 
said: “Have you talked with, you know, the doctor that you usually go to see?”  
[And they reply]  “No, I am not going to talk to him.  I think it has to be done by 
a gynecologist specialist for this” (110114, Female, Non-registered, FP). 
 
A few physicians observed that some women could overcome their preference 
for a specialist if they were interested in saving money.  One female GP who worked 
in a group practice with male gynecologists, benefited from some patient‟s desire to 
save money, perhaps because she was in the same practice as other specialists: 
There are patients who are regularly followed by our gynecologists, who are both 
males.  Obviously it‟s a little more expensive when they go to them for their 
screening, so a lot of them will now choose to come and see me.  They would 
specifically ask to see the female doctor (110322, Female, Non-registered, GP). 
 
 
When asked if a woman would prefer a female family doctor versus a male 
gynecologist, most physicians, female and male, believed that the woman would 
choose the female family doctor.  As one physician stated concisely: “Gender trumps 
specialty” (110315, Female, Non-registered, GP). 
 
KAP: Doctor shopping  
Many Hong Kong people did not have a regular primary care physician, and 
therefore tended to “doctor shop,” as discussed in the literature review.  For these 
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physicians, enrollment in the CSP implied that they would need to encourage their 
patients to be screened, however they expressed concerns that these new patients 
would view recommendations for opportunistic screening suspiciously.  Two quotes 
illustrate physicians‟ concern about building trust before recommending opportunistic 
screening:   
It (opportunistic screening) is one of the routine questions I ask, especially with 
new patients.  I usually wouldn‟t tell them to do it.  I mean I‟ll tell them, I‟ll 
ask them, but they usually won‟t do it right away.  The reason being that I 
don‟t want to make it sound like I want to do it ….because it‟s not free for 
them.  They have to pay for it…I want to increase their readiness, but [I] don‟t 
want them to think that I am trying to do business in a way (110330-01, Non-
registered, GP). 
 
Because it is very odd if you go to see a doctor, you know, and then you just go 
for episodic disease, and suddenly they mention “Have you thought of cervical 
screening?”  You know, we should do that, but maybe some doctors will think 
that: “Will she think that I am trying to get more money from her?”  They 
would think that maybe we should build-up some relationship first.  But in 
Hong Kong, it seems that most people do not have a regular doctor.  So these 
sorts of opportunistic screening activities are very much jeopardized (110114, 
Non-registered, GP). 
 
 
Importantly, some physicians felt that the government program would help 
protect them from appearing mercenary. 
For certain patients, they feel it is not commercial [if a suggestion came from 
the government].  When a doctor sends a reminder they feel…this guy has no 
business.  He wants me to go see him (110104, Registered, FP, private). 
 
Physicians unable to perform cervical screens 
Some physicians did not feel qualified to conduct cervical screens.  One of the 
physician leaders voiced his concern that some GPs would be unable to conduct 
cervical screens, either because they did not know how to conduct a screen, or because 
they did not have the office facilities: 
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The Doctor‟s Union consists of a lot of untrained GPs, you know, grandfathered 
in.  They have good experience, but then they‟ve never gone through proper 
training.  And I would say that forty, fifty percent, may not have proper 
equipment (110104, Registered, FP, private). 
 
 
In this study, none of the physicians interviewed were unable to adopt the CSP 
because they lacked the proper facilities.  However, one physician admitted that he/she 
lacked the technical skills to perform a cervical screen and therefore would refer 
women to a specialist: 
My clinic is a small clinic and sometimes quite busy.  Screening takes lots of 
time, and I am not very familiar with the examination of the uterus and the 
vagina and how to do the smear.  So, usually for this kind of case, I refer to the 
gynecologist (110113, Non-registered). 
 
 
CSP policy differs from physicians‟ preferred screening intervals 
 
Many physicians reported that they screen their patients annually, despite the 
CSP‟s adoption of the Hong Kong College of Obstetricians and Gynaecologists‟ 
guidelines to reduce routine screening to every three years.  Most private physicians 
felt that the CSP‟s recommended three-year frequency was incompatible with their 
usual practice.  In support of their disagreement with the frequency guidelines, 
physicians referenced their need for flexibility, for either clinical (patient) or customer 
satisfaction (business) reasons.  For example, one physician worried, almost 
paternalistically, about her patient‟s sexual health and used an annual screen to trigger 
a more complete check-up: 
Some of them [patients] are on the pill and they‟re actually having more 
partners than they like to admit.  So really part of the Pap smear screening isn‟t 
just a Pap smear screening; it‟s also sexually transmitted disease screening.  So 
in fact I am merging the two things together but that is working within the 
context of being a doctor.  If you look at just cervical screening on its own, then 
there is nothing wrong with it [screening every three years].  But of course the 
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family physician like me is looking at [the] patient as a holistic person (110307, 
Non-registered, FP). 
 
 
The same physician also cited an example of the patient‟s preference for annual 
screens, in support of her patient‟s request for frequent screens: 
A lot of the Pap smears I do are actually people who suggested that they wanted 
a health check, so they do it every one to two years anyway.  So they are the 
people that are probably the “worried well.”  So, yes, so they actually have a 
screen every year, so if I follow the CSP [frequency policy] I will lose my 
client.  It will actually lose business for me.  Even though I will try to advise 
them: “Oh you don‟t need to” (110307, Non-registered, FP). 
 
 
Summary  
All physicians interviewed ranked cervical screening as a very important 
preventive measure.  However, most physicians found the CSP‟s policies to be 
inconsistent with their perceptions of women‟s KAP and their usual practice patterns.  
Among women who had not been screened, many physicians struggled with these 
patients‟ lack of knowledge of screening or cultural barriers, and found it difficult to 
convince their patients of the need for screening.  For those women open to screening, 
physicians reported that their patients‟ preferred female practitioners or specialists.  
Importantly, most physicians found the policy of screening only every three years to 
be inconsistent with their practice; physicians preferred to screen patients at a 
frequency based upon their clinical judgment, or at a frequency that suited the 
women‟s preferences.  Importantly, only one physician did not feel that he had 
adequate skills or facilities to conduct screens. 
 
Key Finding #4: Most physicians typically learned about potentially applicable 
innovations through relatively passive communication channels (communication 
channels).  
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In order to understand which communication channels might influence 
adoption, physicians were questioned about their usual methods of receiving important 
health-related information.  Methods of communication, including mail, email and 
CME, were relatively consistent for both less important communication, and for 
innovations such as the CSP. 
 
Common health-related communication channels 
The physicians interviewed frequently received health-related communication 
from the government, through the mail or electronically, which they generally trusted 
and found helpful.  They also received correspondence from their professional 
associations.  This physician recounted the various methods of information she utilized 
to stay aware of innovations: 
Well, the Department of Health sends everybody, every doctor registered, a 
letter of invitation. And then they have an email system, which I subscribe to. 
And the Medical Association Health System disseminates information.  So I 
think information is no problem, you know, we will always be quite aware of 
what things are going on (110301-01, Registered, GYN, private). 
 
 
CSP communication channels 
Most physicians did not remember any recent communication from the 
government about registering for the CSP or about increasing screening among their 
eligible female patients.  A few did remember receiving introductory information 
about the CSP several years earlier, usually through a mailing.  One physician recalled 
a talk about the CSP: 
There are actually talks organized from time to time about cervical cancer and 
during those seminars we also get information from the Department of Health 
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concerning cervical cancer screening.  But I don‟t think they are something 
new….they [give] information about the cervical cancer screening program in 
Hong Kong (110331, Registered, FP). 
 
No physicians recalled another physician or governmental official championing the 
innovation.  Interestingly, several physicians felt that the pharmaceutical industry‟s 
heavy media campaign to promote the HPV vaccine had played a significant role in 
educating women about cervical health, and indirectly benefitted their practice: 
I guess it comes with the introduction of the cervical vaccine.  I think it comes 
with the increasing awareness to screen for cervical things, including the 
vaccine, but not particularly for cervical Pap smear (110330, Non-registered, 
GP). 
 
People have been talking a lot about cervical screening because the HPV vaccine 
has been evolving in these two years in Hong Kong.  So the public is being more 
and more [aware] of their need for screening (110301-02, Non-registered, GYN). 
 
 
Communication channels for other innovations 
When asked about how they learned about other specific innovations, such as the 
government flu scheme or the HPV vaccine, physicians mentioned mail, email and 
CME.  In general, the physicians interviewed were more likely to learn about medical 
and programmatic innovations passively.  Typically they received a mailing from the 
government, or read about an innovation through professional communication 
channels, such as their professional association‟s emails or newsletters.  Sometimes 
the physicians interviewed were more active in seeking to learn about medical 
innovations by searching through professional channels, such as peer-reviewed 
journals.  This physician had initiated contact with former colleagues in another 
country to learn about evidence-based innovations: 
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I guess there are a few talks, emails, etc., but also I read some articles and 
WHO reports.  Because of the links that I have in Australia, I get all their 
information (11330, Non-registered, GP). 
 
Summary  
Most physicians received regular health communication, as well as information 
on new programs or other innovations like the CSP, through letters, emails, or 
educational CME‟s.  These communication channels were similar for all physicians.  
Importantly, communication from the government was considered trustworthy.  In 
addition, physicians reported that the pharmaceutical industry‟s heavy promotion 
might have indirectly benefitted the uptake of cervical screening. 
 
 
Key Finding #5:  Physicians tended to make rapid decisions about new programs 
without much time for consideration, trial or consultation with others (adoption-
decision process).  
 
Physicians typically did not take much time between their initial awareness of 
an innovation and their decision to adopt it.  This initial decision process was rapid 
due primarily to a truncated persuasion stage.  During this stage, few physicians felt a 
need to try the program or observe another‟s experiences with it; however this differed 
by practice size.  For the few physicians who had registered with the CSP, their 
adoption process was followed by a trial implementation period.  However, after some 
period of time trying the program, all but one physician ultimately rejected the CSP. 
 
General decision-making process 
The solo-practice and clinic-based physicians reported an individual decision 
process that typically considered an innovation‟s scientific evidence, practical 
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concerns, and the endorsing organization.  However while the physicians in group 
practice talked about making individual decisions, they also reported checking with 
each other, as in this example below: 
It was an individual decision.  And after I talk[ed] to the other doctors they are 
convinced as well, so we just [went] ahead (110330, Non-registered, GP). 
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CSP decision process 
Few physicians remembered their initial CSP decision several years before.  
Importantly, of the six physicians that did enroll, only one physician remained active 
in the program.  For these six registered physicians, their adoption and early 
implementation experiences differed by setting.  Among the three private physicians, 
two were unable to articulate either what they experienced as the program‟s benefits or 
barriers, or why they discontinued using the program.  However, the third physician 
retained a clear recollection of his decision to reject the CSP.  In this quote, he 
highlighted the program‟s complexity as a significant barrier that was not balanced by 
enough benefits to prevent him from rejecting the CSP: 
But I think the way it has been organized is probably not a very effective tool, 
you know.  In terms of the Registry and this whole thing; the idea is good, you 
know.  Track, offer support, you know, recall for the doctors and all that.  But 
then in order to get onto the system, it seems so much effort (110104, 
Registered, FP, private). 
 
 
Of the clinic-based physicians that were required to register with the CSP, two 
did not see any relative advantages to the program that could compel them to try it, so 
neither of them used the program.  One of these physicians used a forgotten password 
as an excuse for not using the system: 
Because it has been a very, very long time [since] when it first launched.  But 
we rarely use the system.  I understand I have registered….but I never go to 
review whether I am still in.  I think I have forgotten my password into the 
system as well, because there are so many passwords nowadays (110331, 
Registered, GP, clinic-based). 
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Another registered with the CSP both as a physician and as an individual, but had 
never used the program in either role.  She was emphatic about her lack of interest in 
implementing the program: 
I haven‟t logged into the Internet.  For example as a patientor as a client.  I 
never logged in to look at my own record as a service provider.  I never logged 
in to see: “Oh I have done so many patients and their results are…”  (110325-
02, Registered, FP, clinic-based). 
 
 
The third clinic-based physician was positive about the innovation and was the 
only physician interviewed who actively participated in the program at the time of the 
research.  This physician linked her participation to the public health benefits, rather 
than her perceptions of relative advantages for her practice or her patients: 
[The most important benefit is] to know the epidemiology of the disease.  Then 
we can know how many women in Hong Kong have [had a] Pap smear, because 
if women just go to different clinics then there [are] no statistics about how 
Hong Kong is doing.  But if every woman, no matter [if] they [visit] different 
clinics, can have access to the same program, then [for] Hong Kong, we [will] 
know how many women actually [had a] Pap smear.  So for statistics, I think it 
is very important (110325-01, Registered, clinic-based). 
 
Summary  
The physicians interviewed reported a rapid decision process for both the CSP 
and other innovations, although only those in group practices reported seeking 
information and opinions from office colleagues or professional sources.  Physicians 
who did not adopt the CSP, and two of the clinic-based physicians, appeared to have 
made their final innovation-decision almost immediately, after they decided that the 
program did not offer any relative advantages.  The private physicians who registered 
with the program did begin to implement the CSP, although they also ultimately 
rejected the program, either passively for reasons they could not recall, or actively due 
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to the complexities of the program.  Only one clinic-based physician had sustained use 
of the program, and confirmed her adoption decision.   
 
 
V.  Conclusion 
This study explored the under-participation of private physicians in the CSP.  
Sixteen private and clinic-based physicians, including six who were registered with the 
program, were interviewed to study which factors influenced Hong Kong physicians‟ 
adoption of the CSP.  
The data adequately answer the research question about the factors influencing 
physicians‟ adoption of the program.  This study found that the CSP‟s benefits were 
rarely salient to the physician‟s practices; the program‟s administrative demands were 
considered time-consuming and administratively problematic; and the program‟s 
policies were often incompatible with the physicians‟ typical care practices or their 
perception of women‟s cervical screening KAPs.  As a result, few physicians adopted 
the CSP, and of these, most had negative or non-memorable experiences.  Only one of 
the physicians interviewed was still actively using the program.  Although there were 
differing viewpoints in most areas, the data were relatively consistent across specialty, 
gender, years and size of practice, patient demographics and country of training.   
Exploring physicians‟ perceptions of other recent innovations demonstrated 
that innovations without strong barriers, such as the HPV vaccine, could be adopted by 
Hong Kong physicians.  Similarly, the flu scheme demonstrated that innovations with 
strong barriers but compensatory advantages, such as strong patient demand, could 
also be broadly adopted.  The data indicate that the CSP‟s low adoption rate could be 
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explained by the physicians‟ perception of these barriers to adoption, without 
compensatory benefits.  
Rogers‟ Diffusion of Innovation was helpful as a theoretical framework to 
study the factors that influenced Hong Kong physicians‟ adoption of the CSP, 
although it had its limitations.  Rogers defines diffusion as: “The process by which (1) 
an innovation (2) is communicated through certain channels (3) over time (4) among 
the members of a social system” (Rogers, 2003, p. 11).  Rogers‟ innovation 
characteristics of relative advantage, compatibility, trialability and observability were 
positively correlated with the rate of adoption, while complexity was inversely related 
(Rogers, 2003, 16 – 17).  Applying these constructs to the CSP demonstrated that the 
low rates of adoption can be attributed to the physicians‟ perceptions that the 
program‟s complexity and incompatibility exceeded its limited relative advantages. 
Rogers discusses change agents and thought leaders as two roles that might 
influence adoption of innovations.  It does not appear that the government actively 
sought to utilize change agents or thought leaders as an adoption strategy, and it was 
unclear from this study how influential they might be.  If the government had chosen 
to use physician leaders as change agents, this strategy would have been problematic, 
as the three physician leaders interviewed had negative perceptions about the 
program‟s characteristics.  
Physicians‟ decisions to adopt the CSP are independent of their decisions to 
suggest cervical screening to their patients, although the CSP assumed that 
participation would encourage physicians to conduct more cervical screening.  In this 
study many physicians appear to link the two decisions.  Physicians implied that the 
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barriers to increase cervical screening, such as women‟s KAPs, were perceived as 
additional barriers to adopting the CSP.  Therefore if a physician did not perform 
many cervical screens in his/her current practice, there was no motivation for these 
physicians to join the CSP.  
In addition to the issues with the CSP itself, the data indicated that practice 
patterns do not appear to bridge the gap between prevention-minded physicians and 
high-risk women.  Screening remained an individual patient–physician decision that 
did not prioritize the broader public health goals.  Women who have been screened 
were more likely to visit female GPs or OB/GYN specialists.  These female or 
specialist physicians were, however, the physicians most likely to suggest screening to 
their patients, perpetuating their over-screening.  Conversely, the women who had not 
been screened regularly might frequent various GPs or male doctors that werereluctant 
to suggest screening.  Therefore, these high-risk women might not have beenoffered 
appropriate cervical screening.  
The objective of this study was to explore the factors driving physician‟s 
under-participation in the CSP, in order to inform and influence potential 
improvements to the program.  This study provided some explanation for the lack of 
improvements in cervical screening effectiveness, efficiency or equity, despite the 
CSP‟s efforts with physicians.  Unfortunately, the negative factors driving physician‟s 
under-participation in the program, and the lack of program outcomes, indicate that 
policy changes need to be substantial.  The next chapter, the Plan for Change, explores 
the policy implications of these findings.
  
 
 
 
 
 
CHAPTER 5 
 
PLAN FOR CHANGE 
 
I.  Introduction 
This chapter builds on the key findings to suggest a Plan for Change to inform 
and influence policy considerations.  It begins by reviewing the most relevant findings 
of the research and suggests three policy alternatives to the current CSP policy, as well 
as an evaluation plan.  The chapter then contextualizes the policy environment with a 
brief history of the policy process that led to the establishment of the CSP.  Finally, 
this chapter lays out the Plan for Change to influence this policy, introducing 
Kingdon‟s theory of the policy process to guide the implementation plan.   
The Plan for Change builds on the overall objectives of the CSP.  The CSP 
aimed to increase Hong Kong‟s rates of cervical screening by encouraging physicians 
to increase screening among their patients and by educating and motivating women to 
be screened.  This study focused on the physician component of the program.  In 
analyzing the study findings and presenting the Plan for Change, it is important to 
separate a physician‟s decision to adopt the program from her/his decision to increase 
screening among her/his patients, as they derive from different decision criteria.  The 
data provided insights into the physicians‟ perceptions of the CSP, their perceptions of 
the determinants of their patients‟ cervical screenings, and their adoption-decision 
processes. 
The study findings indicate that the CSP was not conducive to adoption by the 
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physicians interviewed; as most of its characteristics were generally perceived as 
either negative or nominally beneficial (Table 4).  The program‟s primary 
characteristics that were designed to benefit physicians included a patient recall system 
and online access to the patients‟ screening history.  However the physicians did not 
perceive these characteristics as beneficial, because they were redundant to most 
practices' systems.  The CSP also provided evidence-based screening frequency 
guidelines for cost-effective population protection, however these guidelines were 
problematic, as they could affect physicians‟ practice revenues; the physicians 
interviewed reported that reducing the frequency of their patient‟s cervical screens‟ 
from every year to every three years could reduce their related revenues by two-thirds.  
Importantly, those physicians most likely to adopt the program, including both 
physician leaders and physicians whose employers mandated adoption, perceived 
more barriers than benefits to the program. 
For the physicians interviewed, their adoption decision process was rapid.  
These physicians did not perceive the need to conduct further research into the 
innovation or to consult with others.  This rapid decision process can benefit a 
program, as it did for the almost universal adoption of the flu vaccine scheme.  
However for the CSP, the physician‟s rapid decision process may be problematic 
because if the CSP were to be improved, physicians might not be willing to revise 
their decision. 
Finally, the data indicated that many physicians valued cervical cancer 
screening, although some physicians reported cultural and practical barriers to 
increasing rates of screening among their patients.  Some physicians found that their 
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patients‟ lack of knowledge about screening, or their preference for female or 
specialist providers, were significant deterrents to increasing screening.  Other 
physicians who already conducted a large number of screens had little opportunity to 
increase rates, particularly those physicians whoserved a higher socioeconomic patient 
base, those whowere female, or those whowere specialists.  The result of this 
socioeconomic divide was likely to be greater disparity among high-risk, under-
screened patients and low-risk, under-screened patients.  The CSP as it is currently 
designed does not address this issue. 
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Table 4: Implications of Key Findings 
Implications of Key Findings 
Key Finding Implication 
Physicians perceived that the CSP‟s 
benefits were rarely meaningful to 
their practices (Relative advantage) 
 
Little incentive to join the CSP 
Many physicians perceived the CSP as 
time-consuming and administratively 
problematic (Complexity) 
 
Disincentives to join the CSP 
Many physicians found the CSP to be 
inconsistent with their perceptions of 
the women‟s‟ cervical screening 
Knowledge, Attitudes and Practices 
(KAP) and their typical patient care 
practices (Compatibility) 
 
Effectiveness and equity gaps perpetuated, 
as the CSP does not restrain rates of 
overscreening among those physicians 
who currently conduct cervical screening; 
nor does the CSP overcome the obstacles 
to screening among those physicians who 
rarely screen.   
Most physicians typically learned 
about potentially applicable 
innovations through relatively passive 
communication channels 
 
Communication of new programs could 
utilize existing professional channels, 
including government and professional 
organizations. 
Physicians tended to make rapid 
decisions about new programs, 
without much time for consideration, 
trial or consultation with others 
 
If CSP is revised to make it more 
advantageous to the physicians, they may 
not be open to considering adoption again, 
as they already made their decision once. 
 
Unfortunately, the negative perceptions of the program, coupled with the gap 
between under-screened women and the physicians willing and able to screen them, 
indicate that CSP policy changes may need to be substantial.  In essence the strategic 
focus on the physician, needs to be re-assessed.  The following section discusses 
policy alternatives and then recommends an advocacy approach to influence policy 
change. 
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II. Policy Alternatives 
Since the current CSP was not effective in achieving its public health goals, 
policy alternatives were explored.  This study did not include a formal policy analysis; 
therefore the policy alternatives are based upon the research findings and the evidence 
in the Literature Review and will be discussed only briefly.  A formal policy analysis 
would investigate a full range of options from discontinuing the program to offering a 
complete menu of evidence-based components.  This discussion assumes that neither 
policy extreme is feasible.  First, there continue to be public health needs to address 
cervical screening; therefore elimination of the program would be a major setback for 
women‟s health, and discontinuation would be difficult to justify to the stakeholders.  
Conversely, neither the advocates nor the government discern the political will to 
increase funding sharply.  Therefore, this policy discussion will be confined to options 
that assume some level of program presence, yet do not ask for significant amounts of 
additional funding.  A brief evaluation of the policy options, exploring their strengths 
and weaknesses, is also included in the discussion. 
Policy options considered should utilize the large body of international 
evidence to modify the program to be more motivating to physicians or to focus on 
targeting women more effectively.  The most effective evidence-based interventions 
for physicians include financial incentives or multifaceted programs that utilize 
activation methods.  For women, the most effective evidence-based interventions 
address knowledge, psychosocial and access barriers. 
The recommended policy options, discussed below, should target women for 
two reasons.  First, because the government can communicate with women directly, it 
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is easier to control this approach, rather than to try to leverage the physicians‟ referral 
role.  Second, this demand-side approach is more consistent with the government 
philosophy of the public-private approach to policy for social issues.  Policy options 
that target physicians, such as incentives, would be expensive and would contradict the 
government‟s free market philosophy.  In addition, the data about the physicians‟ 
innovation decision processes indicated that physicians maybe reluctant to reconsider 
their decisions to join the CSP.  Therefore, these options should continue to focus on 
the overall objectives of the program and should not include efforts to further engage 
physicians.  Policy options include: 1) a re-attempt to offer population-based 
invitations; 2) additional screening subsidies for high-risk women; and 3) increased 
access to screening using low-cost clinics and more female practitioners.  Finally, I 
recommend that the CSP conduct regular and transparent evaluations of the program‟s 
effectiveness, efficiency and equity. Each policy component is discussed below and 
summarized in Table 5. 
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Table 5: Recommended Policy Components: Strengths and Weaknesses 
Policy 
Component Strengths Weaknesses 
Population-based 
invitations 
 
 Evidence-based 
 Increases efficacy and 
equity 
 
 Requires ruling on data 
privacy law 
 Requires agreement 
from another 
organization without 
public health mandate 
Subsidize 
screening for 
high-risk women 
 
 Increases equity 
 Fits with free market 
philosophy of public-
private partnership 
 Requires additional 
public spending 
 Requires provider 
registration 
Increase 
screening access 
 
 Builds on women‟s 
existing screening 
practices 
 Screening frequency 
more likely to concur 
with recommended 
guidelines 
 Requires additional 
public spending 
 Will take time to train 
screeners 
Evaluate and 
revise program 
 Transparent 
 Allows for program 
correction to best 
achieve goal 
 Requires responsible 
organizations to 
honestly evaluate their 
program, and correct 
any needed changes 
 
 
1) Revisit offering population-based invitations 
I recommend that the CSP re-attempt to offer population-based invitations, as 
this intervention is the strongest evidence-based method to increase screening.  
Population-based invitations are the essential component of organized screening 
programs because they aim to reach all women regardless of their socioeconomic 
situation, age, past screening status, etc.  The key to these invitations is to find a 
comprehensive listing of women. 
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Accessing a population-based registry may be challenging in Hong Kong, 
however the results are measurable and worth pursuing.  Initially the Privacy 
Commission, the organization responsible for evaluating privacy violations, prohibited 
the use of the database for the Hong Kong Identity Cards (HKID) which are issued to 
all adults.  This usage should be revisited as Hong Kong‟s laws were amended after 
SARS in 2004 to accommodate public health needs.  There may now be a legal basis 
to accomplish this acquisition (Choi, 2009).   
The Hospital Authority, the statuary authority that runs all the public hospitals 
and many outpatient clinics, maintains a Patient Master Index (PMI) that could be a 
second possible source for the registry.  After access to HKID registration was denied, 
the Task Force recommended that the CSP should attempt to utilize the PMI.  Most 
women have used public hospital services (particularly maternity services), making the 
PMI a relatively comprehensive source.  Although the Hospital Authority and the 
Department of Health were not able to resolve their software incompatibilities at the 
time of the CSP‟s launch, this database should be revisited to see if there is now a 
technical solution to the incompatibility.   
A third potential source would be the public transportation payment system.  All 
mass transport vendors (buses, trams, and subways) accept a shared value card.  Most 
Hong Kong people use public transport, and have this shared value card, so this source 
would be fairly comprehensive as well. 
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2) Subsidize screening for high-risk women 
A second policy component recommends subsidizing screening by offering cash 
value screening vouchers for high-risk women.  As shown in the Literature Review, 
this subsidy would help eliminate cost barriers for those women who otherwise could 
not afford the cervical screen.  The population-based annual tracking study, the 
Behavioral Risk Factor Survey, highlighted the demographic characteristics of the 
women who are under-screened, that is primarily those over 45 years of age and of 
lower socioeconomic status.  In addition, the CSP should renew its outreach efforts 
through mass media promotions and collaborations with community groups. 
This scheme would be consistent with the government‟s preferred market-
based, public-private partnership model, as it would give vouchers directly to the 
women and they would then be empowered to visit the provider of their choice.  The 
government will need financial accountability for the vouchers, so this option should 
still require participating physicians to register.  However, findings from the research 
demonstrated that patients with flu vaccine vouchers created sufficient demand for 
private physicians to overcome their objections to the administrative demands of the 
program, therefore this policy option could build on that program‟s evidence.   
 
3) Increase access to screening using low-cost clinics and more female practitioners 
 
The third policy option recommends increasing access by building capacity at 
government and NGO multi-site clinics and by utilizing more female screeners.  In 
this study, the physicians that did the most screening were the OB/GYN specialists, a 
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few female GP‟s, and the physicians in multi-site centers.  The study also indicated 
that male physicians were unlikely to screen higher risk women.  Additionally, the 
literature review indicated that women were more likely to see a male physician for 
their regular medical care, given that in the private sector male physicians outnumber 
female physicians at a ratio of 3:1.  
NGO and government health clinics can increase access by increasing capacity 
with longer operating hours and more female screeners.  These clinics are 
conveniently located but they will need to add evening and weekend hours as many 
lower income women have shift jobs, or are otherwise unable to attend during the 
daytime hours.  In addition, the evidence demonstrated that physicians perceive that 
women prefer female screeners, therefore these clinics should increase the use of 
female nurses and foreign-trained doctors (who cannot otherwise qualify to practice in 
Hong Kong) to perform cervical screens.  Female nurses and foreign-licensed doctors 
are less expensive to hire than physicians and should be readily accepted by women.  
As evidence, one Hong Kong study demonstrated that women were more comfortable 
with a competent female nurse than a male physician (Twinn, 2000).  In addition, the 
Hong Kong Family Planning Association has been training and using female nurses 
with positive patient feedback for years (personal communication, 2010). 
Not only are these clinics compatible with women‟s current health behavior 
patterns, but they also offer the added benefit that their practitioners are more likely to 
follow the recommended frequency guidelines (Department of Health and Department 
of Community Medicine, University of Hong Kong, 2004).  
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Evaluate CSP‟s outcomes versus program goals   
Finally, comprehensive and transparent evaluations of the program outcomes 
should be conducted on a regular basis.  Unfortunately, since women‟s participation in 
the CSP is currently minimal, the Registry will not be able to generate adequate 
epidemiological data.  Therefore, data for these evaluations can be compiled from a 
variety of sources.  First, the population-based, annual tracking study, the Behavioral 
Risk Factor survey, should be sufficiently detailed to demonstrate incremental 
screening changes among the demographic and socioeconomic subsegments.  
Although the data are self-reported and not independently verifiable, this tracking 
survey offers the added benefit of nine years of previous data.  Second, to evaluate 
outcome data, the government should partner with the accredited laboratories to 
aggregate screening results and to continue to track the follow-up of abnormal results.  
Finally, Hong Kong‟s Cancer Registry already reports incidence and mortality on a 
population basis; therefore this Registry should contribute long-term outcome data.  
Together these data sources could provide a relatively complete picture of screening 
processes and outcomes.  In addition, efficiency studies can be conducted that build on 
the self-reported data from the Behavioral Risk Factor Survey to model the cost of the 
program versus the financial benefits from reductions in over-screening, and the health 
improvements from growth in screening reach.  
 
Estimated policy expenses 
These policy options should incur recurring expenses for the vouchers for high-
risk women and for training and personnel costs for additional screeners.  Assuming 
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that about 300,000 women over 45 years of age would be eligible for the voucher 
program (Hong Kong Population By-census, 2006) the program cost of a HK$100 
voucher is estimated to be HK$30 million (US$3.8M) over the three-year screening 
cycle.  This voucher should cover different proportions of the cost of providers in 
different settings: it should cover the total cost of a cervical cancer screen at a 
government clinic; about two-thirds of the cost at an NGO clinic; and about half of the 
cost at a private physician.  Additional hours and female screeners at the clinics should 
require more operational funding, although no additional capital costs. These training 
and operational costs can be more optimally estimated when organization-specific 
information becomes available. 
 
Discussion of policy options 
The strength of these recommended policy options is the opportunity they offer 
to increase cervical screening‟s effectiveness and equity.  The program‟s effectiveness 
should be improved by finding a means to increase the reach of the Registry 
information system.  In addition, targeting women at high-risk of developing cervical 
cancer and using evidence-based approaches to reduce screening barriers, addresses 
disparities in current screening practices.  Finally, these policy options should be 
consistent with women‟s current care-seeking behavior, as most Hong Kong women 
are accustomed to choosing their own private physician or to accessing services at 
health clinics. 
Weaknesses of these policy options include the program‟s inability to reduce 
inefficiencies, and the cost of the policy changes.  First, the recommended policy may 
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not optimize efficiency because the program will not be able to regulate the over-
screening practices of the private physicians.  As observed in the research, the 
physicians‟ professional associations that established the screening interval protocols 
have little means of monitoring the individual practices of their members.  In addition, 
women typically pay for their own preventive care; therefore neither the government 
nor insurers can exercise financial control over these private transactions.   
Second, these policy options will have financial costs.  Although Hong Kong‟s 
economy is healthy, any additional budgetary expenses will be difficult to justify.  
This program was conceptualized as a private-public partnership that operated under 
the premise that the government provided the infrastructure and the people paid for 
their own preventive care.  However, even in this free market economy, there is a 
precedent for vouchers to be used to subsidize public health priorities.   
The next section presents the Advocacy Plan.  It builds on the research findings 
that informed the policy options and it aims to apply leadership concepts to those 
options to improve the likelihood of success in implementation.  
 
III. Advocacy Plan  
This section introduces an advocacy plan that fulfills the study objective of 
informing the current cervical health policy and influencing policy change.  The three 
policy options and the recommended evaluation plan are offered as the focus of the 
advocacy effort.  This advocacy plan is a road map that will describe the target 
audience, the implementation and communication plans, and the resources needed to 
influence the policy.  The need for non-traditional leadership skills is also discussed.  
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This advocacy plan begins with a history of past cervical health advocacy in order to 
provide context for the recommended Plan for Change. 
  
Cervical Screening Advocacy History 
Advocacy for cervical health has a substantial history in Hong Kong and future 
advocacy efforts should benefit by building on this history.  This history can be 
analyzed within the framework of John Kingdon‟s theory of the multiple stream model 
of the policy process.  Kingdon‟s theory was chosen as it best represents the policy 
opportunity that created the CSP, and it helps demonstrate the policy barriers to 
improving the program. 
Kingdon‟s theory explained how a particular policy issue might only be offered 
a limited opportunity to be enacted (Kingdon, 1984).  A policy  window is created 
when three streams of actors and processes come together: the problem, the policy and 
the political.  The first stream, the problem, must rise to the level where there is public 
recognition of the problem, usually through some focusing event or feedback that 
raises its profile.  In the second stream, advocates or policymakers work to develop 
and refine alternative policy proposals.  Finally, some event will precipitate a level of 
policy prominence among politicians, such as a perception of national mood or an 
agreement on the issue.  Typically these streams operate independently, until a 
window of opportunity opens and permits policy entrepreneurs to integrate the three 
streams, resulting in policy change (Kingdon, 1984).   
For the CSP, the problem stream (disproportionate rates of cervical cancer), 
advanced initially from the academic and medical communities, before it spread to 
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advocates.  The territory‟s two schools of public health were studying the determinants 
of screening, and the mortality impact of the low rates of cervical screening.  
Researchers had modeled various parameters of an organized screening program and 
found that it could decrease cervical cancer incidence by about 40% (Adab, McGhee, 
Yanova, Wong and Hedley, 2004).  Local research also indicated that the determinants 
of screening in Hong Kong were similar to the global evidence, and that evidence-
based interventions to increase screening might be appropriate if introduced (Adab, 
1999; Adab, McGhee, Yanova, Chin, Wong & Hedley, 2000; Chang & Hazlett, 2002; 
Twinn, Holroyd, Fabrizio, Moore & Dickinson, 2005, Leung, 2010). 
I initiated the patient advocacy effort in the early 2000‟s, while working at the 
Hong Kong Cancer Fund (HKCF).  The HKCF is an NGO that provides cancer 
information and professional support to anyone affected by cancer.  Inspired by the 
toll enacted by this preventable cancer, I led the NGOs growth into advocacy.  Gary 
Yukl defines leadership as a “process of influencing others to understand and agree 
about what needs to be done and how to do it, and the process of facilitating individual 
and collective efforts to accomplish shared objectives” (Yukl, 2006, p. 8).  Yukl‟s 
leadership strategy enabled the transition from advocacy vision to execution of policy.  
The initial efforts were limited as funding was secured for a promotional campaign 
while I reached out to stakeholders and allies to broaden and deepen the program.  The 
second and third year the efforts merged with the academic and medical communities‟ 
advocacy efforts to launch an evidence-generating, community-based Cervical Cancer 
Coalition.  This was a partnership consisting of grass-root women‟s and cancer 
advocacy groups, academics, physicians, NGO and government clinics, and consumer 
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product companies that marketed to women.  The coalition developed advocacy 
leaders through an organic process outside traditional leadership models that helped to 
further develop the advocacy efforts (Erickson, 1995). 
The fourth year, the problem, political and policy streams were integrated 
during a policy window that was successful in obtaining government commitment for 
a cervical screening program.  A Cervical Screening Task Force was established to 
develop the policy parameters.  In Hong Kong, this type of policy-making task force is 
customarily composed of government officials, academic experts and physicians‟ 
association leaders.  However, because of our work advocating for the issue, the 
HKCF was allocated a position on the task force.  The Cervical Screening Program 
was developed and introduced in 2004, and the task force still retains the obligation to 
monitor and evaluate the program.  
 
Advocacy plan: target audience 
London (2008) acknowledges that advocacy is a process. Rather than beginning 
with a defined plan, advocacy may be initiated by a perceived need, in this case the 
need to address Hong Kong‟s disproportionate incidence and mortality rates of 
cervical cancer.  Advocates next define the goal, which generally stated here is the 
need to improve the CSP to address effectiveness, efficiency and equity.  Then 
advocates develop their strategy, including recognizing the stakeholders, forming 
alliances, and identifying the policy targets. Finally the advocates implement their 
plans of action, with specific strategies focused on SMART goals, that is goals that are 
specific, measurable, attainable, realistic and timely (London, 2008).   
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Although most stakeholders in cervical health are well established, this 
advocacy plan benefited from a Power Map approach to identify and classify all the 
targets (London, 2008).  The process of Power Mapping not only helped to  identify 
the stakeholders and their roles in the advocacy process; it further contextualized the 
policy environment by illuminating other potential connections and power structures, 
and acknowledging opposition.  Power mapping was a three-step process of: 1) 
identifying all the stakeholders and their potential role in the advocacy process; 2) 
placing them into the four quadrants of a map defined by the degree of their power and 
influence, and their support for policy change; and 3) evaluating the key targets using 
advocacy parameters.  The result is a clear Plan for Change, within these parameters. 
These three steps are described in more detail below. 
The first step in the process was to analyze the stakeholders in order to identify 
and classify the groups who should be allies, beneficiaries and potential opponents, 
decision makers, and influencers (Figure 8).  The organizations are listed below, 
although it is their leaders who are the specific targets for the advocacy plan.  The first 
group was the academic community.  My own department, the HKU School of Public 
Health (SPH), was a natural ally given their past history of advocacy and placement of 
academic members on the task force.  The head of the SPH and a professor in health 
economics have both committed their support for the improvement of the CSP.  
Professor Sheila Twinn, who generated a large body of research on cervical screening 
behavior during her career at Hong Kong‟s other prominent SPH, has been a key 
supporter of this effort.  Both universities have advocated for cancer control measures 
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for many years and the advocacy plans cannot be carried out without support and 
leadership from these two schools. 
The primary beneficiaries identified were women‟s and cancer advocacy 
groups, as they should directly benefit from the policy‟s efforts to improve women‟s 
health.  The third group of beneficiaries identified was the NGO multi-site clinics.  
They should also benefit from these policy changes as they were recommended to 
receive additional funding for training and operational capacity. 
The next roles identified by the mapping process were the policy‟s likely 
opponents and decision-makers.  Given the DOH‟s past reluctance to discuss or 
evaluate the CSP, this department was the stakeholder most likely to actively oppose 
this policy.  In addition, the policy changes should also require cooperation with the 
government‟s Hospital Authority (HA), which may resist the data cooperation plan.  
Unfortunately, these likely opponents were also identified as the decision makers, as 
the former organization has responsibility for the CSP and the latter owns the potential 
registry source.  In addition, the Treasury Department was identified as a secondary 
decision-maker as Hong Kong‟s budget is influenced by the Treasury‟s priorities. 
Finally, the likely influencers were the professional physicians‟ associations.  
This category included many organizations usually organized by specialty or advanced 
certification, including the Hong Kong College of Obstetrics and Gynecology, the 
Hong Kong Academy of Medicine, the Hong Kong College of Family Medicine, the 
Hong Kong Society of Cytology, the Hong Kong College of Pathologists and the 
Doctors‟ Union.  These associations have a long shared history and on-going projects 
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with the government, although as independent practitioners they often differ on policy 
issues.  
Figure 8: Power Map Step 1: Identification of Roles 
 
Step 1: Identification of Roles 
Allies 
 
 
 
 Academic Community (Medical Schools and Schools of Public 
Health at University of Hong Kong and the Chinese University 
of Hong Kong) 
Beneficiaries 
 
 
 
 Women‟s groups (Hong Kong Federation of Women, The 
Women‟s Foundation, Hong Kong Women Worker‟s 
Association, etc.) 
 Cancer Advocacy Groups (Hong Kong Cancer Fund, Hong Kong 
Anti-Cancer Society) 
 NGO multi-site clinics (Family Planning Association, Tung Wah 
Hospitals, United Christian Nethersole) 
 
Opponents 
 
 
 
 Department of Health  
 Hospital Authority  
  
Decision 
Makers 
 
 
 
 Department of Health (Secretary for Food and Health, Mr. York 
Chow) 
 Hospital Authority (Chairman, Anthony Wu) 
 Treasury Department (Secretary for Financial Services and the 
Treasury, Prof. K.C. Chan; Permanent Secretary for the 
Treasury, Mr. Stanley, YH Ying; Deputy Secretary for Financial 
Services and the Treasury, Ms. Alice Lau) 
Influencers 
 
 
 
 Physicians‟ Professional Associations (Hong Kong College of 
Obstetrics and Gynecology, Hong Kong Academy of Medicine, 
Hong Kong College of Family Medicine, Hong Kong Society of 
Cytology, Hong Kong College of Pathologists, Doctors Union) 
 
Next these stakeholders were plotted on a power map to help determine the 
advocacy targets (Figure 9).  First, the academic community was placed just above 
mid-point on the influence scale, although in the supportive change quadrant.  Hong 
Kong is a relatively small community; therefore many of the powerful government 
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figures studied at the two universities and there is a symbiotic relationship between 
academics and government.  Women‟s and cancer advocacy groups were placed in the 
lower right quadrant, as unfortunately they do not have much political power.  
Conversely, the sizes of the multi-site clinics and their roles in previous public-private 
partnerships give them more power; therefore they were the second group in the 
influential top right quadrant.  The government departments, although most likely 
unsupportive of policy change, were placed in the top left quadrant to show their 
importance; the larger Hospital Authority was placed slightly above the Department of 
Health.  Finally, although this research demonstrated positive support for cervical 
screening, and the physicians‟ associations have a large role on the Cervical Task 
Force, they were placed low in the top left quadrant until their position on this policy 
is known. 
  
93 
 
 
Figure 9: Power Map Step 2: Choosing Targets 
 
These targets were then evaluated to determine the advocacy strategy.  Three 
groups were selected as advocacy targets (Figure 10).  Physicians‟ associations, and 
women and cancer advocacy groups were the first two targets addressed, for their 
support, their accessibility, and their power positions.  The advocacy leadership goal 
for them is to galvanize their support and motivate them to influence the key target, 
Step 2: Choosing Targets 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Cancer Advocacy Groups 
More power / 
influence 
Support 
change 
Less power / 
influence 
NGO Multi -
Site Clinics 
DOH 
Physicians’ 
Associations 
Women’s Groups 
Oppose 
change 
Academic 
Community 
 
Hospital 
Authority 
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the DOH.  The third group, the DOH was the institution with the decision-making 
power, and therefore the ultimate target.  This evaluation is utilized in the 
implementation plan, later in the chapter. 
 
Figure 10: Power Map Step 3: Evaluating Targets 
 
Step 3: Evaluating Targets  
Checklist Criteria 
Target Option #1: 
Physicians‟ 
professional 
associations 
Target Option #2: 
Women‟s and cancer 
advocacy groups 
Target Option #3: 
Department of Health 
(DOH) 
Knowledge of the issue 
(High, medium, low) 
 
Medium 
 
Medium 
 
High 
Support objectives 
(Yes, No, Maybe) 
Yes Yes No 
Accessibility: 
 Vulnerable? 
 Able to switch sides? 
 Firm in position? 
 Can we neutralize 
their opposition? 
May differ by 
specialty; HKAM 
and specialties with 
advanced 
certification will 
support; others are 
uncertain 
Always have been 
supportive, although 
may be distracted by 
other priorities 
(women‟s groups: new 
minimum wage laws, 
social welfare needs; 
cancer advocates: 
additional funding for 
treatment and support)  
Priorities often 
dictated by crisis or 
budget constraints 
What information / 
arguments are most 
likely to sway them? 
Evidence; 
Potential to drive 
their practice 
Preventable cancer can 
be reduced efficiently; 
government has not 
delivered on promise 
This policy will align 
with other public-
private partnerships 
and is politically 
popular 
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Step 3: Evaluating Targets (cont.) 
Checklist Criteria 
Target Option #1: 
Physicians‟ 
professional 
associations 
Target Option #2: 
Women‟s and cancer 
advocacy groups 
Target Option #3: 
Department of Health 
(DOH) 
Can we influence them? 
 Do they know our 
organization? 
 Do they respond to 
our constituency? 
 Do we have 
influence in their 
constituency? 
Potential to reach 
and influence them, 
through current 
Task Force and 
connections with 
academic 
community 
Potential to influence 
through history of trust 
and close working 
relationship 
Potential to influence 
through Task Force 
members and 
physician 
constituencies 
Do they have political 
or positional power? 
Yes Occasionally, on key 
issues; maybe on this 
issue 
Yes 
 
 
 
Implementation Plan 
This identification and evaluation of the stakeholders and advocacy targets was 
used to inform development of the implementation plan.  The plan highlights the 
leadership skills that should be needed for implementation and acknowledges the 
continued role of the Cervical Cancer Task Force.  Then the plan discusses the 
communication strategy in detail. 
Specific leadership skills will be needed to drive this advocacy effort.  
Advocacy is unique because it draws upon non-traditional leadership models for 
change.  The primary type of leadership needed for this effort has been defined as 
transformational leadership, where an advocate leads with her passion, inspiration and 
relationships (London, 2008).  Another key type of leadership derives from influence; 
Yukl defines “power” as the capacity of one person to influence another, versus the 
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authority that comes from one‟s position in an organization (Yukl, 2006, p. 146).  
Closely tied to this influential power, a third type of leadership derives its power from 
one‟s experiential knowledge of an issue.  Finally, while perhaps not strictly 
leadership skills, advocacy leaders need to employ strong interpersonal skills to assess 
the issues that are important to their partner stakeholders, and strong communication 
skills to channel their voices into the shared advocacy program (Agnew, 1999; Wasay, 
2005).  These skills were essential during the first advocacy effort and now advocates 
should again use these unique sources of power to lead efforts to change policy. 
Importantly, the advocacy effort should take advantage of the Cervical 
Screening Task Force and work with, and through, the members as much as possible.  
The Task Force is composed of the key stakeholders identified in the power map, 
including leaders from the medical and public health academic communities, the 
DOH, physicians‟ associations, multi-site clinic providers, and cancer advocacy and 
women‟s groups.  This body of participants is the organization that generated initial 
commitment and resources for the CSP, and its members are the most likely to lead the 
endeavor to support the change in policy.   
From the commencement of the CSP, the Task Force was charged with 
evaluation and oversight of the screening program on an on-going basis.  However the 
DOH program managers have not facilitated these fiduciary responsibilities.  In 
personal communications over the past year, three different members of the Task 
Force expressed concern that they were not fulfilling their responsibilities for 
monitoring the program.  These Task Force members were concerned that for the last 
three years they have not had meetings, nor received program status reports, or more 
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importantly, had not received a comprehensive program evaluation.  This concern may 
be widespread among other Task Force members, and can be leveraged to reactivate 
their advocacy commitment.   
This plan should be executed in steps, as each group‟s support is essential to 
gaining the support from the next group approached (see Figure 11).  Communication 
should begin with the various ally and beneficiary stakeholders, and should seek to 
enlist their support both for the policy changes and for approaching the influencers.  
As described above, the academic allies will be approached through my personal 
contacts, although both Schools of Public Health have members on the Task Force.  I 
work for HKU‟s SPH and already have general commitment from a key professor and 
the department chair, pending the outcome of the research.  I can also ask Sheila 
Twinn or a current facility member on the Task Force to facilitate a meeting with the 
leadership of the Chinese University‟s SPH. In these meetings, I will share my 
research findings and ask for their support.   
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Figure 11: Advocacy Timetable 
 
The effort to gain the support of the beneficiaries will utilize personal 
relationships, as I have worked with these groups in the past and they have 
representatives on the Task Force.  However the two beneficiary groups are very 
different and will require different tactics to gain their support.  The cancer and 
women‟s groups tend to be led by social service professionals or community 
organizers, while the NGO multi-site clinics are run by professional physician leaders. 
For the cancer and women‟s groups I will need to employ strong communication skills 
to help them understand the data and its implications, in order to motivate them to 
support this issue.  However, most of the NGO leaders were involved in helping 
develop my research questions and facilitating interviews with their employees; 
therefore my approach to them will emphasize shared concerns to reinforce their 
commitment to improving the policy.  
When these stakeholders are committed, the advocacy effort should 
subsequently engage the influencers, which is the various physicians‟ professional 
associations. While working with physicians can be challenging due to their limited 
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availability, relevant groups (GPs, FP, and GYNs) are represented on the Task Force 
and I also have personal relationships with most current or past presidents.  
Importantly, leaders of the FP and ED associations were also involved in helping 
develop the research question and facilitating interviews with their members. Although 
I work for HKU, my research was conducted as a UNC student; therefore my 
leadership power will derive from my many years of knowledge and advocacy in this 
policy area, rather than institutionally-based leadership power. In addition, I will 
employ coalition-building strategies by seeking the assistance of both the NGO-clinic 
physician leaders, as they are closely involved with their professional associations, and 
the academic allies, as they also have similarly familiar relationships with these 
professional groups. 
Once the influencers are committed, the advocacy effort should leverage the 
influencer-stakeholder‟s access to approach the decision-makers.  During the early 
stages of this research, academic allies were unable to help gain access to the DPH 
decision-makers.  Therefore this advocacy effort will now utilize the influence of the 
physicians‟ associations to arrange the first meeting.  This stakeholder group should be 
more successful than the academic stakeholders, as they are the group most directly 
involved in the CSP.  Alternatively, I will work with the other committed stakeholders 
that are members of the Task Force (cancer and women‟s groups, academics and 
NGO-clinics) to jointly request a meeting with the DOH.  This later method is least 
preferred since it may be premature at this first effort at communication to employ the 
combined influence of several stakeholders.  This larger advocacy coalition should be 
reserved to influence the final policy decision. 
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The nature of this incremental advocacy plan will require an extended time 
frame for execution.  The advocacy leaders should determine if this issue can be 
driven internally and kept within the policy confines of the DOH, or if the issue needs 
to be elevated to the larger political discourse.  Importantly, during this 
implementation process, stakeholder groups should be encouraged to introduce 
alternative policy options, as the alternative ideas may strengthen the policy options 
advocated and should further engage the advocate partners. 
Other recent public health policies, such as tobacco tax increases and nutritional 
labeling, offer successful models for policy change and can be studied to guide this 
advocacy effort. For example advocates working to raise the tobacco tax heavily 
promoted the benefits of the policy among the public, and the nutritional labeling 
advocates engaged independent research on the policy‟s benefits to be used to educate 
the relevant government department. In addition, both public health advocacy efforts 
utilized coalitions of academic, medical and consumer groups.  Fortunately, many 
members of the Task Force are veterans of other policy battles, and can offer strategic 
guidance.  
Throughout this process, the advocacy plan must acknowledge and comply with 
the cultural concept of face.  This concept is an important construct in Chinese culture, 
somewhat similar to the Western construct of reputation.  In a situation where a 
program failed, or someone erred, it is important to finds a means for the program or 
person to save face by not necessitating public admission of failure.  The issue is 
resolved when a solution is suggested that corrects the situation without blame or 
acknowledgement of wrongdoing.  In this policy situation, the advocacy effort must 
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keep in mind the need for the government, and the Task Force, to save face.  For 
example, the advocacy effort should position potential policy changes as 
improvements to the existing policy, rather than corrections. 
  
Advocacy targets 
Below the implementation plan is discussed in detail for each stakeholder target: 
 Target Option #1: Physicians‟ professional associations 
As shown in the power map analysis, physicians‟ association‟s support is 
crucial to influence the DOH.  This research study demonstrated strong support for 
cervical screening among key informants, yet the physicians did not support the 
CSP.  The advocacy communication plan should decouple the participation in the 
CSP from the issue of increasing cervical screening rates.  Discussions should 
acknowledge the negative findings about the CSP, which should assist in the effort 
to enlist the associations‟ support, and to reduce the associations‟ potential 
defensiveness about individual physicians‟ lack of participation. 
Since the target group analysis showed that this group was more likely to 
be influenced by evidence, discussions with physicians‟ associations should utilize 
a policy brief (outlined below) that emphasizes the research.  The College of 
Family Physicians, the College of Obstetrics and Gynecology, and the Hong Kong 
Academy of Medicine should be approached first, as these associations are the 
most directly involved in this issue. 
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 Target Option #2: Women‟s and cancer advocacy groups 
As key beneficiaries, women‟s and cancer advocacy groups have been 
supportive of the cervical screening policy from the commencement of the initial 
advocacy effort.  Approaches to these groups should be facilitated by my past 
experience working for the Hong Kong Cancer Fund and my current volunteer 
work with women‟s groups.  The challenge will be to mobilize their support now, 
as there are many other topical equity issues in policy discussions, such as the 
institution of a minimum wage, and revisions to retirement pension policy.  
Women‟s issues have been overlooked in recent government policies, therefore 
communication with these groups should sympathize with their concerns and 
position this advocacy effort as one that is focused on addressing the screening 
disparities among women. 
 
 Target Option #3: Department of Health 
The communication plan should culminate with the DOH.  This ultimate 
advocacy target should not be approached until: a) the policy options have the 
support of most of the Task Force members and stakeholder groups; and b) the 
advocacy plan has been adapted based on all stakeholder input.  The 
implementation plan suggests that the physicians‟ associations approach the 
Department‟s leaders, as they are the stakeholders most likely to influence 
government officials.  Given that the DOH may have conducted their own internal 
program evaluation, discussions should learn about the department‟s thinking 
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before discussing the gap between the CSP‟s goals and the disappointing 
outcomes.   
Findings from this study should be used to suggest explanations for the poor 
outcomes.  The communication approach to the DOH should position cervical 
screening as an essential component of primary care, aligned with the new primary 
care initiative.  Although the department‟s priorities are often determined by health 
crises, made more urgent by heavy media coverage, these particular discussions 
should not be media events.  Small meetings will facilitate reasoned discussion of 
the evidence and the policy options to mitigate the continued burden of disease.  
Discussions should highlight the breadth of the dissatisfaction about the CSP, and 
the support for policy change, to add political impact. 
 
Resources 
This advocacy effort should have enough data and potential policy options to 
begin the implementation plan but will need to develop some written advocacy tools.  
Fortunately, this implementation plan will require the application of personal resources 
more than independent funding.  Throughout the effort, advocates should regard the 
Cervical Screening Task Force as their greatest resource.  The specific tools needed are 
described in more detail below. 
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Additional tools: 
1) Policy briefing paper:   
A policy briefing paper should be developed for discussions with the influential 
targets, drawing on publicly available information and the key findings of this 
dissertation (see Table 11 for timing).The briefing paper‟s objectives should be to: 
 Remind key stakeholders of the situation, which is the burden of the disease, 
the objectives of the CSP, and the outcomes to date against these objectives. 
 Share the research results and a summary of the Behavioral Risk Factor Survey 
data.  The policy brief should include the program‟s limited results in addition 
to the findings of this study, which indicate that the significant issues with the 
design of the program might explain the disappointing screening results 
overall.  This research was done with a relatively small sample, therefore the 
data should be introduced with appropriate caution. 
 Ask for their support for the recommended policy options. 
 
2) Article in local physician‟s journal 
An article for a local peer-reviewed physician journal, the Hong Kong 
Practitioner, should have a similar goal as the briefing paper, although it should be 
shorter and targeted to the general physician community.  It should focus on the 
need to increase cervical screening and should discuss the recommended policy 
changes.  Summary data of the research should show the low perceptions of the 
CSP‟s innovation characteristics, while emphasizing that participation in the CSP is 
not a prerequisite to increasing cervical screening among one‟s patients.  This 
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journal reaches both community-based physicians and government; therefore it 
should ideally appear during the process of obtaining support from physician 
leadership and before approaching the Department of Health. 
 
IV. Conclusion 
This chapter presented a Plan for Change to influence the cervical screening 
policy.  It first reviewed this study‟s key findings that were the most relevant to inform 
the cervical cancer screening policy.  However, the findings indicate that the CSP‟s 
characteristics were not appealing to the physicians, and that the changes needed to 
make them attractive were expensive and philosophically inconsistent with government 
policy.  Therefore, this chapter suggested drawing on both the research findings and the 
literature for effective interventions to increase screening, to focus the CSP‟s benefits on 
motivating women.   
A brief history of the policy process that led to the establishment of the CSP was 
provided to contextualize the policy environment.  The chapter then offered three policy 
options that focused directly on increasing screening among women, supplemented with 
a recommendation to evaluate and publicize the results of the program‟s effectiveness, 
efficiency and impact on disparities. Justifications for elements of the policy options 
were also based upon findings from the study.  A rough cost estimate of the policy 
options was calculated.  This chapter then laid out a Plan for Change to influence this 
policy, using the framework of Kingdon‟s theory of the policy process.  
Within the Plan for Change, a power map process was used to identify the issues, 
allies, beneficiaries, opponents, influencers and decision-makers.  All targets were 
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evaluated for their relative power and support, with a more in-depth analysis of the top 
three targets: physicians‟ associations (influencers), women‟s and cancer advocacy 
groups (allies), and the Department of Health (decision-maker and opponent).  Finally, 
an implementation plan was presented which offers an incremental roadmap to build 
support and influence, while working toward an opportune policy window for change.  
The implementation plan includes a discussion of how each step will take place, and a 
timetable with the critical items noted.  The last chapter of this dissertation will discuss 
the public health implications for this Plan for Change.  
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CHAPTER 6 
DISCUSSION 
 
This chapter discusses the public health implications of the recommended Plan 
for Change.  It reviews the current status of cervical health in Hong Kong, the potential 
improvements to be gained, and the way the plan should use the research findings to 
influence policy in order to maximize public health.  This chapter then identifies the 
potential limitations of the plan and explains why the advantages outweigh the 
drawbacks.  
 
Current status of cervical health in Hong Kong 
Unfortunately, seven years into the CSP, there have been few improvements to 
the national participation rates of screening.  The latest data from the Department of 
Health reported ever-screened rates of 63.3%, which is virtually flat versus the 63.9% 
rate reported in 2004 when the program began (DOH, 2010).  Efficiency has gone down 
since the CSP was introduced, with the rate of over-screened, low-risk women (those 
who report screens “once or more a year”) up from 56.0% in 2003 to 62.8% in 2010 
(DOH, 2010). Fortunately, there were minor reductions in disparities over this time, with 
increased participation among the subsection of high-risk women aged 55–65, reporting 
screening rates of 72.1% in 2010, versus 67.5% in 2004 (DOH, 2010).  However, on 
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balance the CSP does not appear to have moved towards its public health goals for 
cervical health.  
 
Potential public health benefits for Hong Kong 
If Hong Kong could develop a more effective cervical health program, the 
potential gains are substantial.  Other countries with organized screening programs have 
achieved reductions in cervical cancer ranging from 70-80%, following the 1980‟s 
widespread use of the Pap test (Day, Williams, Khaw, 1989; Cancer Research UK, 2003).  
In addition, these countries have maximized their efficiency and reduced disparities by 
optimizing their attendance rates (Koopmanschap, 1990).  Hong Kong-specific models 
have estimated that optimizing screening reach and frequency could achieve further 
reductions in incidence rates of almost 45%, with an efficiency gain of a 40% reduction 
in the number of Pap tests needed to find a single case of invasive cancer ( Adab, 
McGhee, Yanova, Chin, Wong and Hedley, 2000; Adab, et al., 2004;Woo, 2005). 
 
The  Plan for Change 
The Plan for Change endeavors to build on this study‟s research findings to 
influence the CSP policy in order to realize the potential public health gains.  The plan 
began with a comparison of the components of the CSP versus the components for 
evidence-based organized screening programs.  It acknowledged that the CSP was 
developed within Hong Kong‟s philosophy of free markets.  The Plan for Change will 
seek to inform policymakers how the program‟s characteristics were not attractive to 
physicians, and subsequently to influence evidence-based policy changes.    
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The Plan for Change recommends policy modifications that draw upon the 
evidence in the Literature Review, including 1) re-attempting to offer population-based 
invitations; 2) introducing subsidies for high-risk women; and 3) increasing screening 
access by building capacity at low-cost clinics and adding more female practitioners.  In 
addition, a detailed evaluation plan is recommended.  The Plan for Change identifies and 
analyzes advocacy targets, using a power map process to contextualize the policy 
environment.  A specific communication plan was developed for the top three advocacy 
targets: women‟s and cancer advocacy groups (allies), physicians‟ associations 
(influencers), and the Department of Health (decision-maker and opponent). The 
advocacy plan should take a thoughtful and step-wise approach to build strategic support, 
and it should adapt the policy options as appropriate.  This plan should utilize advocacy 
leadership to build support and influence, while working toward an opportune policy 
window for change. 
However, the Plan for Change has limitations.  As discussed, the policy options 
might not be able to dramatically reduce screening inefficiencies and they might require 
new expenditures, although not a significant amount.  However, the Plan‟s largest 
limitation arises in the policy arena.  Kingdon‟s concept of a policy window opened for 
cervical health when the CSP was introduced in 2004.  However, since then the 
government‟s medical attention has shifted to more urgent infectious diseases, such as the 
H1N1 influenza.  The government is also working on other systemic health care policy 
changes, such as broadening access to private insurance (Bauhinia Foundation, 2007, 
Lee, 2011), and building a culture of preventive care by encouraging family doctor 
relationships (Lee, 2011).  These policies affect more of the population than just women, 
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or just high-risk women. In addition, cervical screening is not currently a government 
priority, particularly since a program is already in place.   
Due to the current policy environment, the Plan for Change suggests working 
through influential people without engaging the media; this method should provide more 
opportunity for policy change without the government losing face.  The implementation 
plan discusses the leadership challenges for this Plan for Change, and the ways that 
advocacy‟s unique leadership skills can influence policy. 
Influencing policy will be a leadership challenge, particularly if advocacy is 
driven as an “outsider” without institutional power, such as me.  This policy challenge is 
compounded because the government has been reluctant to discuss the CSP.  In the last 
three years they have not convened or updated the CSP Task Force and have reduced 
promotional efforts for the public and the physicians.  The officials responsible for the 
program have also passively resisted efforts to speak with Task Force members and 
advocates, despite my offer to conduct a comprehensive program evaluation at my own 
expense.  This resistance may indicate other priorities or a lack of resources, or that the 
government has already concluded that the CSP is not a viable program. 
 
Implications for Future Study 
New research has demonstrated the potential of the HPV vaccine to prevent 
cervical cancer.  However it will be another 20-30 years before the cohort of women who 
have received the HPV vaccine will enter the period when they are most at risk of 
developing cervical cancer.  It has also not yet been determined if the vaccine will have 
the unintended consequence of increasing rates of cervical cancer among other HPV 
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strains not addressed by the vaccine.  Importantly, policy strategies recommended here to 
address screening‟s effectiveness and equity should be applicable to the development of 
an HPV vaccine strategy; the vaccine is expensive and has already further distorted 
disparities in cervical health (Gramham & Mishra, 2011).  Unfortunately, the public 
resources required to reduce these disparities will be substantial, as the HPV vaccine is 
more expensive than Pap tests. 
 
Final Word 
This Plan for Change should improve public health by helping to reduce the 
incidence and mortality of cervical cancer.  It should also help to reduce the cervical 
cancer disparities that particularly affect older and poorer women.  Although Hong 
Kong‟s incidence and mortality rates have been declining over time, its rates are not on 
the downward trajectory commensurate with the territory‟s counterparts in other 
developed countries. This gap represents lives that could have been saved.  
Hong Kong has already experienced seven years with an ineffectual Cervical 
Screening Program, although it was launched with the best of intentions. Public health 
policy should move forward as more data becomes available; in Hong Kong, advocates 
should take the program‟s public outcomes and this exploratory research data to work 
toward strengthening the program.  Although advocacy leadership is outside the 
traditional model of leadership, the history of the CSP demonstrates that advocacy 
coalitions have previously accomplished significant policy change. It is my hope that 
advocacy leadership and a clear Plan for Change should again drive policy toward 
improving cervical health in Hong Kong. 
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Appendix A: 
 
Key Definitions 
 
Cancer Registry: System of ongoing reporting of cancer patients in a defined population.  
More broadly, a Registry is a research institute that utilizes a cancer register and other 
information for epidemiological research (International Agency for Research on Cancer, 
2005). 
  
Cervical cancer incidence rate: The rate at which new cases of cervical cancer occur in a 
population (International Agency for Research on Cancer, 2005). 
 
Cervical cancer mortality rate: The rate at which deaths from cervical cancer occur in a 
population (International Agency for Research on Cancer 2005). 
 
Cohort effect: Effect of an etiological exposure or medical or societal intervention that 
affects differently persons born in successive birth cohorts (International Agency for 
Research on Cancer, 2005). 
 
Colposcopy: Magnified visual examination of the cervix using a low-power stereoscopic 
binocular field microscope with a powerful light source (International Agency for Research 
on Cancer, 2005). 
 
Cost effectiveness: An analysis of the costs relative to the effectiveness of a procedure or 
activity, or comparisons of similar activities to determine the relative degree they will 
achieve similar effectiveness (International Agency for Research on Cancer, 2005). 
 
Diffusion:  
 The passive process by which a program or product is absorbed into more widespread 
use, NCI Consensus Definition (Schiffman, Schneider, Murray, Brugha & Gilson, 
2008). 
 The outcome of the dissemination effort (Rogers, 2003).  
 
Dissemination 
 The active promotion or support of a program to encourage its widespread adoption, 
dissemination involves the adaptation, evaluation, implementation and maintenance of 
an intervention (Schiffman, Schneider, Murray, Brugha &  Gilson, 2008). 
 The planned process of creating awareness of the program or interventions among the 
targeted population, informing stakeholders about the innovation and persuading them to 
try it (Rogers, 2003). 
 
Effectiveness: The reduction in incidence of and/or mortality from invasive cervical cancer 
due to screening practice, under real conditions and among those in the target population 
(International Agency for Research on Cancer, 2005). 
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Efficacy: The reduction in incidence of and/or mortality from invasive cervical cancer under 
ideal conditions (in randomized trials) among those screened compared to the incidence or 
mortality in those randomized not to be screened but compliant if invited to be screened 
(International Agency for Research on Cancer, 2005). 
 
Hong Kong Estate doctors: “A special group of general practitioners who practice in housing 
estates with a designated population catered for by a single „estate doctor.‟  They provide 
services for longer than usual hours at affordable prices.  This is possible because of a 
„guaranteed‟ patronage by residents of the estate.  The qualifications of this group of doctors 
vary, with most of them learning their clinical skills from experience” (Li, 2003, p. 2). 
 
Hong Kong General practitioners: Physicians with no higher qualification (Li, 2003, pg. 2). 
 
Hong Kong Licentiate doctors: Doctors who were trained and obtained their qualification 
outside Hong Kong.  The majority of these doctors are from Mainland China” (Li, 2003, p. 
2). 
 
Organized screening program: Screening programs organized at national or regional level, 
with an explicit policy that includes several essential elements from target population to 
treatment (International Agency for Research on Cancer, 2005). 
 
Opportunistic screening: Screening outside an organized or population-based screening 
program, as a result of, for example, a recommendation made during a routine medical 
consultation for the woman, consultation for an unrelated condition on the basis of a possibly 
increased risk for developing cervical cancer or by self-referral (International Agency for 
Research on Cancer, 2005). 
 
Overdiagnosis: Detection of cervical cancers or pre-invasive lesions that would never have 
progressed to be clinically recognized during a woman's life (International Agency for 
Research on Cancer, 2005). 
 
Overtreatment: Treatment of lesions that would never have progressed to be clinically 
recognized during a woman's life (International Agency for Research on Cancer, 2005). 
 
Participation rate: Proportion of those screened among those invited according to the 
scheduled policy (organized screening).  In a program not based on invitations, participation 
has the same meaning as coverage (International Agency for Research on Cancer, 2005). 
 
Primary screening: Detection of cases of cervical cancer or of its precursor lesions among 
asymptomatic women without a referral diagnosis (International Agency for Research on 
Cancer, 2005). 
 
Target population: The population eligible for screening, i.e., all women recommended to 
undergo screening according to the policy adopted (International Agency for Research on 
Cancer, 2005). 
 
114 
 
Screening policy: Specific policy of a screening program which dictates the targeted age 
group, the geographical area, the screening interval, etc.  Note that both organized and 
opportunistic systems may have policies (International Agency for Research on Cancer, 
2005). 
 
Screening test: Test, applied to all women in a program, which results in discrimination 
between those who test positive from those who test negative (e.g. Pap smear).  Those who 
test positive will be recalled or referred for further assessment or diagnostic confirmation 
(International Agency for Research on Cancer, 2005). 
 
Sustainability: Making an innovation routine until it reaches obsolescence (Greenhalgh, et 
al., 2004). 
 
Triage: Detection of cases of cervical cancer or of its precursor lesions among women who 
were initially found to have an abnormal screening test that requires further evaluation 
(International Agency for Research on Cancer, 2005).    
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Appendix B: 
 
 Physician Discussion Guide 
 
Introduction: 
Hello.  My name is Cecilia Fabrizio and I am a student in the Executive Doctoral Program in 
Public Health at the University of North Carolina in the States.  X suggested that I contact 
you about this study of the Cervical Screening Programme.   
 
Provide consent: get signature 
 
Thank you for agreeing to participate in this Study.  This study will look at the physician‟s 
experience with Cervical Screening.  I have asked to interview you since your practice 
includes women of age eligible for cervical screening.   
 
Background Questions: 
1) What is your specialty?  (i.e. Family practice, General Practice; OB/GYN) 
 
2) Did you train in Hong Kong?  If not, where did you train? 
 
3) How long have you been in practice in Hong Kong? 
 
4) What is the background of the women in your practice, such as the district they 
primarily come from, and the percent under and over 65 years of age? 
 
Baseline questions about cervical screening:  
1) Do you remember reading any professional articles or promotional materials about 
the need for increased cervical screening in the last three months?  What about in 
the last year? 
 
2a) Do you do any cervical screening of your female patients?   
 
2b) Can you estimate how many screens you conduct in an average month?   
 
2c) (If they do cervical screening) On a scale of 1 to 10, compared to other preventive 
health practices you use with your patients, how important is it to conduct cervical 
screening for your female patients?    
3) Are you aware of the government’s Cervical Screening Program (CSP)? 
 
If they ARE aware of the CSP? 
 Are you registered with the CSP? 
If yes,  
 What do you think about the CSP?   
 What are the benefits of the program? 
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If they are aware of the CSP but not registered, skip to 1b:  
 
If they are NOT aware of the CSP, begin with Q1: 
Diffusion Questions 
Read physicians the description of the CSP 
1)  Innovation Characteristics:   
1a) What benefits of the program are most interesting to you? 
 
1b) Are there any barriers to your participating in the program?  If yes, please 
explain.  
Prompts: 
Relative advantage vs. current screening practice? 
Compatibility 
Complexity 
Trialability 
Observability 
1c) Would you consider participating in this program?   
 
2) Personal network and communication channels:  
 
2a) Can you give an example of a recent innovation that you adopted into your 
practice? 
 
2b) Tell me how you typically learn about new policies or medical innovations that 
you incorporate into your practice?   
Prompts: 
 Interpersonal channels, such as other physicians, professional societies, CME 
 Mass media channels, such as communications from DH, professional journals 
and mass media 
 
2c) Which of these methods had the biggest influence on your decision to adopt that 
new medical practice or technology into your practice? 
 
3) Innovation-decision process: (information-seeking and information-processing) 
a. Awareness knowledge 
b. How-to knowledge 
c. Principles knowledge (prevention) 
 
3a) When did you become aware of the innovation, in your example? 
- Was it due to a health need you saw in your patients, or an awareness of the 
public health need for screening?  (selective perception) 
- (If it was awareness)  Do you remember how it happened – was it through an 
outside person or source; even mass media? 
 
3b) What aspects of the innovation, if any, are the most beneficial for you? 
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3c) Once you were persuaded of the benefits of the innovation, were there other 
factors that helped you to make the final decision to adopt the innovation?  
 
3d) How long did it take from when you first heard about the innovation to 
implementing it in your practice? 
 
 
Closing: Thank you again for your time.  Your information and insights are important to this 
study.  I can provide you with a summary of the final study, once the University of North 
Carolina has approved it (expected by December 2011) 
1
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Appendix C: 
 
Cervical Screening Program Description 
 
The Hong Kong Cervical Screening Programme 
All registered medical practitioners are invited to join the Cervical Screening 
Programme.  This program is a public – private partnership that aims to reduce the 
incidence and mortality of this common, preventable women’s cancer.   
The program follows the guidelines of the Hong Kong College of Obstetricians and 
Gynaecologists (HKCOG). 
- Women aged 25 – 65 are encouraged to have regular screening, along with other 
high-risk female populations 
- After two annual, consecutive negative smears, women should be screened every 
three years until they turn 65, or until they have a hysterectomy 
 
The Department of Health‟s new Computer Registry records all screens, tracks quality 
measures and issues reminders for your patients.   
 
Benefits for physicians:  
• Have your clinic information displayed in the Cervical Screening Programme website 
(www.cervicalscreening.gov.hk). 
• Receive a free training kit containing VCDs, Cervical Screening Manual and publicity 
materials such as booklets and pamphlets.  The training covers technical skills in smear 
taking and communication skills to clients. 
• Have access to clients' past cervical smear results online, using the Authorization Code 
provided by clients. 
• Receive the lists of clients due or overdue for the next smear to facilitate recall of clients. 
• Your patients will receive a reminder letters to attend for regular smears. 
• Receive summary statistical report on individual patient smear results.  
• Receive a Certificate of Participation issued by the Department of Health. 
 
Physicians can register online or via fax.   
Evidence shows that brief advice from doctors is effective in increasing uptake of 
cervical screening. 
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Attachment D: 
 
Coding Guide 
 
These definitions and decision rules were used as a guide during the coding process. 
 
 
I. Rogers’ Diffusion of Innovation Construct Codes: Perceived Attributes of 
Innovations: 
The following Rogers‟ constructs applied to both: 
A) Cervical Screening Program (CSP) 
B) Another innovation – this was typically another government program (flu voucher, 
elderly primary care voucher, or electronic medical records tied to the public hospital 
system) or a medical innovation, such as the HPV vaccine. 
 
 Relative Advantage: “Degree to which an innovation was perceived as better than 
the idea it supersedes.” 
Decision rules: 
o “Idea” here applied to the practice patterns (reminder system, ability to check past 
screening results, etc.) or to screening practices (frequency, age initiated or ended, 
etc.) 
o Could have been positive or negative 
 
 Compatibility: “Degree to which an innovation was perceived as being consistent 
with the existing values, past experiences, and needs of potential adopters.” 
Decision rules: 
o Values, experiences and needs included practice patterns or screening 
practices 
o Could have been be positive or negative 
 
 Complexity: “Degree to which an innovation was perceived as difficult to understand 
and use.” 
Decision rules: 
o Could be difficult for the physician and/or her/his office staff 
o Could have been positive or negative 
 
 Trialability: “Degree to which an innovation was perceived to be able to be 
experimented with on a limited basis.” 
Decision rules: 
o “Experimented with” could include an actual trial after registration 
o Could have been positive or negative 
 
 Observability: “Degree to which the results of an innovation were visible to others.” 
Decision rules: 
o Visibility could have been in a formal setting, such as CME or other 
professional setting, through written materials, or even through conversation. 
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o Could have been positive or negative 
 
II. Rogers’ Diffusion of Innovation Construct Codes: Innovation Decision Process 
The following Rogers‟ constructs apply to both: 
A) Cervical Screening Program (CSP) 
B) Another innovation – this is typically another government program (flu voucher, 
elderly primary care voucher, or electronic medical records tied to the public 
hospital system) or a medical innovation, such as the HPV vaccine. 
 
 Innovation: How aware: Through which channels did the physician become aware 
of the innovation  
Decision rules: 
o Could have been interpersonal, mass media, targeted professional channels, 
etc. 
 
 Innovation: Decision Time: How much time elapsed between the first awareness of 
the innovations: a) the decision to adopt the innovation; and b) the implementation of 
the innovation 
Decision rules: 
o Differentiate between the time for the decision and the time for the 
implementation 
o If it was an annual program, use only the first instance of decision and 
implementation 
 
 Innovation: Decision Factors: Which factors were important in the physician‟s 
decision about the innovation  
Decision rules: 
o May have included both the channel of communication and the attributes of 
the innovation 
 
 Innovation: Influence: Of the methods used to convey information to the physician 
about the innovation, which was most influential in the physician making the 
decision? 
Decision rules: 
o May have included both the channel of communication and the attributes of 
the innovation 
 
III.  Additional Emergent Codes 
 Women’s Knowledge, Attitudes and Behavior (KAP): Physicians‟ thoughts on 
what motivates or inhibits a woman‟s screening practices, including: 
 Male vs. Female Doctors: Physicians‟ thoughts on whether or not women 
have a gender preference for cervical screening, and why they might have that 
preference, based upon their practice experience 
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 Specialist: Physicians‟ thoughts on whether or not women have a preference 
for the type of physician to conduct their cervical screen, and why they might 
have that preference, based upon their practice experience 
 Other: Other concerns, issues, etc. 
 Business Framework:  Physicians often describe or think about their practice as a 
business.  This may include “costs” such as expenditures, revenues gained or lost, and 
resources used. 
 
III. Descriptive Codes: Codes used to identify descriptive, background information on 
physicians.  Note these codes were not used for the analysis process, but as background 
data, or as an indication of the breadth of data analyzed. 
 
 CSP Registered: Are they registered with the CSP? 
 Training: Where did they do their training (typically in Hong Kong, other countries, 
or a combination of both) 
 Practice Demographics: The socio-demographic background of their female 
patients, aged 25 – 65 years  
 Specialty: Medical specialty, and any advanced qualifications 
 CS-Imp of screening:  On a scale of 1 (low) to 10 (high), how important did they 
rank cervical screening as a preventive practice for their female patients 
 Reminder Systems: Did the practice have a method of reminding women when they 
are due for a cervical screen? 
 Number of screens / month:  A physician‟s estimate of the average number of 
cervical screens she/he conducted per month, either scheduled or opportunistically. 
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Appendix E: 
 
Summary of Key Findings  
by Registered versus Non-Registered Physicians 
 
R = Registered 
NR = Not Registered  
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